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Nerve autografts are widely used clinically to repair nerve grafts.  However, nerve 
grafts have many limitations, such as, availability of donor nerve grafts, and loss of 
function at donor site.  To overcome these problems, we have used a tissue engineering 
approach to design three-dimensional (3D) scaffolds containing laminin-1 (LN-1) and 
nerve growth factor (NGF).  After nerve injury and during embryonic development, 
several extra-cellular matrix molecules and neurotrophic factors contribute to nerve 
regeneration and repair.  Our 3D agarose hydrogel scaffolds with gradients of LN-1 and 
NGF are designed to mimic these in vivo conditions to promote nerve regeneration in rats. 
To determine the effect of LN-1 gradients on neurite extension in vitro, dorsal 
root ganglia (DRG) from chick embryos were cultured in 3D hydrogels.  A gradient of 
LN-1 molecules in agarose gels was made by diffusion technique.  LN-1 was then 
immobilized to the agarose hydrogels using a photo-crosslinker, Sulfo-SANPAH 
(Sulfosuccinimidyl-6-[4’-azido-2’-nitrophenylamino] hexanoate).  Anisotropic scaffolds 
with three different slopes of LN-1 gradients were used.  Isotropic scaffolds with uniform 
concentrations of LN-1, at various levels, were used as a positive control.  DRG cultured 
in anisotropic scaffolds with optimal slope of LN-1 gradient extended neurites twice as 
fast as DRG in optimal concentration in isotropic scaffolds.  Also, in the anisotropic 
scaffolds the faster growing neurites were aligned along the direction of LN-1 gradient. 
To promote nerve regeneration in vivo, tubular polysulfone guidance channels 
containing agarose hydrogels with gradients of LN-1 and NGF (anisotropic scaffolds) 
were used to bridge 20-mm nerve gaps in rats.  Nerve autografts were used as positive 
 xiii
controls and isotropic scaffolds, with uniform concentration of LN-1 and NGF, were used 
as negative controls.  After 4-months, the rats were sacrificed and nerve histology was 
done to test for nerve regeneration.  Only anisotropic scaffolds and nerve autografts 
contained evidence of axonal regeneration.  Both groups had similar numbers of 
myelinated axons and similar axonal-diameter distribution.  However, nerve graft group 
performed better in functional outcome as measured by relative gastrocnemius muscle 
weight (RGMW) and electrophysiology.  Optimization of performance of anisotropic 
scaffolds by varying the LN-1 and NGF concentration gradients might lead to 
development of scaffolds that can perform as well as nerve auotgrafts for nerve 




Chapter 1.  INTRODUCTION 
 
1.1. Aim of Thesis 
 The aim of my thesis is to develop anisotropic tissue-engineered scaffolds to 
promote enhanced nerve regeneration across a challenging 20-mm long nerve gap in rats, 
as compared to isotropic scaffolds. 
 
1.2. Problems and Challenges of Peripheral Nerve Injuries 
Injuries to the peripheral nervous system (PNS) occur frequently and are a major 
source of disabilities.  PNS injuries impair the ability to move muscles, to feel normal 
sensations, and result in painful neuropathies.  As neurons are terminally differentiated, 
repair of injuries to the nervous system necessitates regeneration of neural tissue.   
PNS injuries are classified as being traumatic, non-traumatic or surgical in nature. 
Traumatic nerve injuries result from collisions, motor vehicle accidents, gunshot wounds, 
fractures, lacerations or other forms of penetrating trauma.  In 2002, more than 250,000 
patients suffered traumatic peripheral nerve injuries in U.S.A [56].  Of these patients, 
only 15% could be treated due to difficulties in treatment.  Even among the patients who 
received treatment, more than 50% did not show any measurable signs of recovery or 
suffered from drastically reduced muscle strength.  Most of the non-traumatic peripheral 
nerve injuries are attributed to nerve compression and adhesion.  In 2002, more than 
400,000 repair procedures were done in U.S.A. to correct carpal tunnel syndrome, a non-
traumatic nerve injury.  Although treatments for non-traumatic nerve injuries have higher 
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efficacy than traumatic nerve injuries, patients still suffer from pain, loss of muscle 
strength and dexterity for several weeks to months.  Surgical injuries result from 
procedures such as prostatectomy, to remove prostate tumors.  Prostatectomy procedures 
most often require sacrificing one or both of the cavernous nerves, adversely affecting 
erectile function and bladder control.  In 2002, more than 260,000 patients in U.S.A. 
suffered major injuries to cavernosal nerves due to prostatectomy procedures [56].  In 
order to repair these nerve injuries, several techniques have been used. 
The simplest technique for nerve repair, in case of nerve transection injuries, is 
reconnecting the two ends of the nerve using sutures or fibrin glue.  However, in many 
cases there is loss of nerve segment due to injury, or there might be a time lag between 
injury and surgical repair during which the nerve ends might retract, resulting in a nerve 
gap.  In such cases, end-to-end nerve suturing cannot be done without creating tension in 
the nerve segment, resulting in a poor regeneration outcome [115].  To overcome this 
problem, the two nerve ends are approximated using grafts, such as nerve 
autografts/allografts, muscle grafts, vein grafts, muscle-vein grafts and synthetic nerve 
guidance conduits/channels (NGCs).  
Historically, during the 19th and early-20th centuries, various materials were used 
to promote nerve repair, such as bone [44], metal tubes [97], blood vessels [129] and fat 
sheaths [67], to guide the regenerating axons to the distal stump.  The use of autologous 
nerve grafts was also first reported during this time [5].  However, due to improper 
surgical techniques, anatomical repair rarely led to an appreciable return of function.  
During World War II, surges in numbers of nerve injuries led to advances in 
microsurgical techniques and instrumentation.  Further refinements in microsurgical 
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techniques, revolutionized by Millesi [94], and drug therapies have had beneficial effects.  
Significant advances in surgical techniques have been achieved, and now biological 
factors rather than surgical techniques are limiting improvements in nerve regeneration.  
Further advances may come from greater understanding of the molecular mechanisms of 
nerve regeneration, advances in nerve cell culture, development of new biomaterials and 
genetic techniques. 
 
1.3. Nerve Autografts and Their Limitations 
At present, nerve autografts are considered the “gold standard” for bridging nerve 
gaps in cases of PNS injuries [83].  Autologous tissue grafts, such as nerve autografts, 
veins, muscles etc., possess several advantages.  They are likely to be more 
biocompatible than artificial materials, are less toxic and provide a support structure to 
promote cell adhesion and migration [36].  However, there are several disadvantages with 
this technique.  Obtaining natural graft leads to loss of function, as well as potential 
neuroma formation at donor sites, requires multiple surgeries, and multiple small grafts 
are needed in case of a long nerve gap.  There could be a problem of size mismatch 
between the donor nerve graft and injured nerve.  In addition, complete functional 
recovery is seldom obtained even with autografts [70].  Therefore, there is interest in 
developing techniques to not only enhance the performance of autografts [34,47,136], but 
also synthesize alternatives with better functionality than autografts.  Analytically, natural 
or artificial grafts used to bridge nerve gaps can be thought to have four central 
components germane to regeneration: 1) scaffold/substrate, 2) growth factors, 3) 
extracellular matrix (ECM) molecules and 4) cells.  The current techniques for nerve 
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regeneration try to provide all or combinations of the four components for nerve 
regeneration.  
 
1.4. Polymer Nerve Guidance Channels for Nerve Regeneration 
To replace autografts for peripheral nerve regeneration, a wide variety of natural 
materials have been used, such as, bone, autologous muscle grafts [92], vein grafts 
[20,124], tendon grafts [14], muscle-vein combined grafts [96].  All have exhibited 
encouraging results in a research setting but suffer from the drawback that tissue must 
still be removed from the patient, leading to loss of other functions. 
Tubular nerve guidance channels (NGC) made of synthetic materials has also 
been used to bridge nerve gaps with promising results [2,68,90].  NGCs with inner 
diameter slightly larger than the diameter of the nerve being repaired are used.  This 
strategy involves securing the proximal and distal ends of the nerve to the two open ends 
of the NGC.  These tubes physically guide or funnel sprouting axonal processes towards 
their distal targets.  In addition to restricting migrating cells and sprouting processes 
within the confines of the tube, such systems create a space for increasing the local 
growth factor concentrations and act as a barrier to minimize the infiltration of fibroblasts 
and other inhibitory or scar forming entities that would otherwise inhibit the normal 
regenerative process [120].  Guidance channels have been widely used in tissue 
engineering to repair peripheral nerve injuries, the various kinds of NGC being used are 
discussed in more detail in section 1.8.2. 
 
1.5. Nerve Regeneration using NGC  
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Nerve regeneration in silicone NGC has been studied in detail [130].  Within a 
few hours of nerve repair using NGC, the tube fills with serum exuded by the injured 
blood vessels in the nerve ends.  This fluid contains neurotrophic factors, as well as 
several cytokines and inflammatory cells such as macrophages.  The macrophages help 
remove the myelin and axonal debris formed due to injury.  The fluid also contains the 
clot-forming protein, fibrin.  From day 3 to day 7 post-repair, the fibrin coalesces and 
forms a longitudinally oriented fibrin cable bridging the two nerve ends.  Without the 
formation of the fibrin cable, axonal regeneration cannot occur, thus making the fibrin 
cable formation a very critical step.  From day 7 to day 14, the fibrin cable is invaded by 
cells migrating from the proximal and distal nerve stumps, including fibroblasts, 
macrophages, Schwann cells and endothelial cells (which form capillaries and larger 
vessels), followed by axons.  From 2 to 8 weeks, some of the axons from the proximal 
end grow into the fibrin matrix, reach the distal nerve end and proceed to the final target 
tissues, and are simultaneously myelinated by Schwann cells.  During nerve regeneration, 
axons are guided to their targets by a combination of contact mediated cues such as 
extracellular matrix (ECM) proteins, and diffusible cues including neurotrophic factors 
secreted by Schwann cells and macrophages [40,116].   
 
1.6. Role of Schwann Cells in Nerve Regeneration 
In the PNS, Schwann cells are support cells that wrap around the axons.  A 
Schwann cell forms a multilamellar sheath of myelin, a phospholipid-containing 
substance, around an axon that serves as an insulator and increases nerve conduction 
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velocity.  An individual Schwann cell may ensheath several unmyelinated axons, but only 
one myelinated axon, within its cytoplasm. 
Schwann cells of uninjured nerves are quiescent. Following nerve injury, the 
Schwann cells become ‘reactive’ and proliferate.  Schwann cells migrate into the injury 
site and then form cell cords (known as bands of Büngner) within the basal lamina tubes, 
and the regenerating axons grow in close contact with these cords [16].  Impeding the 
migration of Schwann cells prevents the growth of injured axons through the grafts [53].  
The ‘reactive’ Schwann cells have been shown to offer a highly preferred 
substrate for axon migration and release bioactive factors that further enhance nerve 
migration [7].  For instance, Schwann cells produce ECM molecules such as laminin and 
collagen, and express many cell adhesion molecules and receptors including L1, N-
cadherin, γ1 integrins, and neural cell adhesion molecule (N-CAM).  Schwann cells also 
synthesize and secrete a cocktail of neurotrop(h)ic molecules such as nerve growth factor 
(NGF), brain derived neurotrophic factor (BDNF), and ciliary neurotrophic factor 
(CNTF) [117].  These ECM proteins and neurotrophic factors are essential for survival of 
neurons and axonal migration [26,39,54,87].  Researchers have attempted to take 
advantage of the cellular functions of Schwann cells to promote regeneration in both PNS 
and CNS, as described below. 
 
1.6.1. Techniques Using Schwann Cells for Nerve Regeneration 
Using Schwann cells in NGCs bypasses the fibrin cable formation step, 
accelerates the formation of bands of Büngner, and introduces a persistent source of 
neurotrophic factors, leading to more efficient nerve repair.  When saline filled guidance 
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channels are implanted, Schwann cell migration into their lumen is a critical step for 
peripheral nerve regeneration [37,53].  Using Schwann cells has lead to enhanced nerve 
regeneration in both PNS and CNS [48,131].  When Schwann cells are seeded into nerve 
conduits, the injured peripheral nerves regenerate at a much faster rate [15,51].  This 
could decrease the time required by the axons to reconnect to the target organ, as well as 
increase the distance over which regeneration occurs.  Schwann cells isolated from the 
peripheral nerve of a patient, and expanded in vitro, could be used to treat the patient’s 
nerve injuries.  Addition of Schwann cells has been shown to significantly improve the 
performance of various scaffolds, such as empty NGCs, collagen gels, venous nerve 
grafts and muscle grafts, as compared to control scaffolds without Schwann cells 
[7,64,112].   
The success of nerve auotgrafts for peripheral nerve regeneration is attributed 
primarily to the Schwann cells they contain.  For instance, acellular nerve segments do 
not function as well as Schwann cell-containing autografts [125,126].  The ability of 
Schwann cell-seeded NGCs to promote regeneration was found to be dependent on the 
Schwann cell seeding density and immunocompatibilty between donors and host [48].  
Using Schwann cells from a genetically identical source (syngenic) in rats, it was 
observed that increasing the seeding density improves the nerve regeneration outcome.  
Heterologous Schwann cells elicited a strong immune reaction, impeding the nerve 
regeneration [48].  Also, the ability of NGCs containing Schwann cells to facilitate nerve 
regeneration is dependent on the density of pre-seeded Schwann cells [48].  To obtain 
Schwann cells from a patient, an additional surgery is needed to obtain a small nerve 
segment that will serve as source of Schwann cells, and it takes 5-6 weeks to grow a 
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therapeutically relevant number of Schwann cells, during which time the injured nerve 
further degenerates [79].  Therefore, the current techniques for Schwann cell 
transplantation are not clinically acceptable. 
 
1.6.2. Techniques Using Other Cell Sources for Nerve Regeneration 
As an alternative to Schwann cells, other cells could be used as such or 
genetically modified, to produce desired levels of neurotrophic factors, or to express 
specific extracellular matrix molecules.  Fibroblasts, genetically modified to produce 
NGF, BDNF, NT-3 and bFGF, showed promising results in CNS regeneration [95].  
Olfactory ensheathing cells have been shown to promote regeneration of cut nerves in the 
adult rat spinal cord [80].  Although these are examples of CNS regeneration, the 
genetically modified cells can be used for PNS regeneration also. Addition of bone 
marrow stromal cells to NGCs has shown improved regeneration over empty NGCs in 
rabbit peroneal nerve model [23].  Similarly, pluripotent stem cells derived from hair 
follicles have shown improvements in mice [6].  However, the difficulties of isolating 
and culturing these cells from the patient prior to surgery, could limit this approach for 
clinical applications.   
 
1.7. ECM Proteins, Neurotrophic Factors and PNS Regeneration 
Schwann cells have been shown to offer a highly preferred substrate for axonal 
migration and release bioactive factors that further enhance this process.  Schwann cells 
produce two kinds of molecules that are relevant for nerve regeneration: haptotactic 
proteins, that are substrate-bound or cell surface-bound extracellular proteins, such as 
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laminin-1 (LN-1), collagen, L1, N-cadherin, and NCAM; and diffusible chemotactic 
proteins such as nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), 
and ciliary neurotrophic factor (CNTF).  The success of peripheral nerve and Schwann 
cell transplants is essentially due to their ability to secrete ECM proteins such as LN-1 
and trophic factors like NGF in response to injury [33,81]. 
 
1.7.1. ECM Protein, Laminin 
The ECM molecules are present in the basement membrane of cells, and include 
laminin, fibronectin, collagen, tenascin, thrombospondin and heparan sulfate 
proteoglycans.  ECM molecules, especially laminin and fibronectin, play vital roles in 
cell migration, adhesion, proliferation, differentiation and neurite outgrowth in the 
nervous system during development and regeneration [77,99]. 
Laminin is the first ECM molecule to be expressed during embryonic 
development, suggesting its high importance during ECM organization [82].  Laminin is 
a potent stimulator of neurite outgrowth, enhances attachment and migration of neuronal 
cells, increases survival of neurons and stimulates neurite outgrowth in neurons from 
peripheral and central nervous systems [1,9,13,25,29,101,102].  After peripheral nerve 
injury native Schwann cells have been shown to increase production of laminin to induce 
regeneration.  When nerve grafts pre-treated with laminin-1 antibodies were transplanted 
across a sciatic nerve gap in rodents, a 52% decrease in axon ingrowth into nerve grafts 
was observed [125], suggesting that laminin-1 is critical for nerve regeneration.   
Laminin is a large cross-shaped glycoprotein (Mw = 900,000) found in the 
basement membrane of most non-neural tissues and dispersed through out the nervous 
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system.  Laminin molecule is a heterotrimeric molecule, composed of three polypeptide 
chains: α, β and γ chains.  These chains are structurally homologous but differ in their 
amino acid sequences, resulting in different isoforms of the chains (i.e. α1, α2, α3 etc.) 
and hence different members of the laminin family.  Laminin has at least 10 isomers, 
from laminin-1 to laminin-10 [82].  
Localization studies using isoform specific antibodies in the human fetal tissues 
(18-19 weeks) have revealed that laminins are expressed in a tissue specific manner [82].  
Laminin-1 (α1-β1-γ1) is expressed in brain, especially in neuroretina, olfactory bulb, and 
cerebellum, meninges, as well as in kidney and testis.  Laminin-1 was the first member of 
the laminin family to be isolated and is also the best studied member of this family.  
Laminin-1 can be readily purified in large quantities from Engelbreth-Holm-Swarm 
(EHS) tumor.  Hence, most studies of the effects of laminin in vitro have been carried out 
with laminin-1.  Laminin-1 promotes neurite formation, neurite outgrowth and neuronal 
survival.  In addition, laminin-1 guides axonal path finding, cell migration and adhesion 
[82].  Laminin-2 (α2-β1-γ1) is expressed in cardiac, skeletal muscle and peripheral nerve.  
Laminin-2 promotes neurite extension and mediates Schwann cell myelination [82].  
Laminin-3 (α1-β2-γ1) is expressed in neuromuscular junctions and renal glomeruli 
(kidneys).  Laminin-3 helps in recognition of synaptic sites during development and 
regeneration.  Laminin-4 (α2-β2-γ1) is expressed in Schwann cells and skeletal muscle.  
Laminin-4 is involved in Schwann cell myelination.  Laminin-5 (α3-β3-γ2) and laminin-6 
(α3-β1-γ1) are expressed primarily at dermo-epidermal junctions.  Laminin-7 (α3-β2-γ1) 
is expressed in human amnion.  Laminin-8 (α4-β1-γ1) and -9 (α4-β2-γ1) are expressed 
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primarily in human chorion.  Laminin-10 (α5-β1-γ1) is expressed in human amnion and 
keratinocyte cultures.   
On the laminin molecule, two specific segments of peptide sequences (IKVAV 
and LQVQLSIR) have been identified for neurite outgrowth and cell attachment [82].  
However, these sites are not active with all laminin-responsive neuronal cells, and some 
cell-type specificity is observed in the neuronal cell response.  This suggests that 
additional sites on laminin exist for neurite outgrowth and that more than one receptor for 
signaling neurite growth may exist.    
Cells interact with laminins through a number of cell surface receptors and 
binding proteins.  The receptors and binding proteins that bind laminin to cell surfaces 
and mediate adhesion and neurite outgrowth are: (1) Integrins of the β family; (2) Non-
integrin binding proteins that bind specific sequences in one of the polypeptide chains; 
and (3) Carbohydrate-binding moieties such as lectins that bind galactose and pol-N-
acetyllactosamine groups in oligosaccharides.  The binding of laminin to its receptors 
activates and initiates the signals mediated by protein kinase cascades, GTPase, and 
intracellular calcium fluxes.  These secondary signals modulate a variety of cell 
responses such as attachment to a substrate, migration and neurite outgrowth during 
embryonic development and regeneration [69].  
 
1.7.2. Neurotrophic factor, NGF 
The distal end of the transected nerve exerts trophic influences on regenerating 
axons [17].  Neurotrophic factors, including neurotrophins such as NGF and BDNF are 
produced by Schwann cells following nerve injury and dispersed diffusely in a gradient 
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fashion around regenerating axons.  Regenerating axons extend along the density gradient 
of neurotrophins to the distal segment [72].  Apart from NGF and BDNF, Schwann cells 
also produce other neurotrophins, such as, insulin-like growth factor (IGF), ciliary 
neurotrophic factor (CNTF) and fibroblast growth factor (FGF). Neurotrophic factors are 
crucial for the development and survival of the mammalian nervous system [78].    
Although all the above compounds stimulate peripheral nerve migration directly 
or indirectly, NGF is a very important and best-characterized neurotrophic factor for 
peripheral nerve regeneration.  NGF is a dimeric, 27 kDa neurotrophic factor.  NGF is 
produced in the target organs of the sympathetic and sensory nerves, and is conveyed to 
the cell body retrogradely in the PNS [8].  Intact sympathetic and sensory nerves contain 
low titer of NGF-mRNA as compared to their target organs [54].  However, following 
axotomy, Schwann cells in the distal segment start producing NGF and reach a peak at 24 
h.  This 10- to 15-fold elevated level is maintained for at least 2 weeks after axotomy [54].  
NGF has been shown to stimulate and promote the survival of sensory ganglia and nerves, 
including spinal sensory nerves and sciatic nerves [78,118].  Griffin et al. [46] have 
shown concentration-dependent neurite extension/retraction with NGF levels.  NGF has 
been shown to prevent the death of axotomized sensory neurons completely following 
exogenous administration [100].  There is enough evidence to show that gradients of 
neurotrophins help in guiding developing as well as regenerating axons in a wide variety 
of neuronal systems [49,50].   
Receptors for NGF include trkA (a NGF-specific, high affinity receptor, 40 kDa 
glycoprotein) and p75NTR (a low affinity, 75 kDa glycoprotein) [98].  NGF receptors, 
after binding to NGF, become activated by the ligand mediated oligomerization of 
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receptors and the following autophosphorylation of their tyrosine residues [61].  The 
activation of NGF receptors initiates a cascade of signaling events and leads to neuronal 
differentiation [107]. 
 
1.7.3. The Combined effects of ECM proteins and Neurotrophic Factors for PNS 
Regeneration 
 In neuronal development and in adult nervous systems, substrate-bound neurite 
promoting ECM proteins and chemoattractive diffusible trophic factors influence and 
stimulate axon guidance and neurtite extension [66,99].   ECM proteins affect cell 
interactions during the development, maintenance and regeneration of the nervous system 
[58].  Neurotrophic factors support growth, differentiation and survival of neurons in the 
nervous system [65].  
 LN-1 and NGF have been used separately in different studies to promote neuronal 
survival and extension.  However, LN-1 and NGF, used together, promoted significantly 
better nerve regeneration than either one of them used separately [132], suggesting that 
LN-1 and NGF might be acting synergistically to promote better neurite extension.   
 
1.8. Tissue Engineering Strategies for PNS Regeneration 
Tissue engineering techniques are being used to develop constructs to replace 
natural nerve grafts.  Tissue engineered constructs for nerve regeneration consist of one 
or more of the four components: (i) scaffold, usually tubular NGC along with structural 
elements such as fibers, gels etc., (ii) growth factors, (iii) ECM proteins, and (iv) cells.  In 
 14
general, scaffolds for nerve repair should support axonal proliferation, have low 
antigenicity, support vascularization, be porous for oxygen diffusion and avoid long term 
compression. The scaffold can be made from natural or synthetic materials. 
 
1.8.1. Natural Materials as Scaffolds 
Natural materials, including veins, skeletal muscle fibers and collagen, have been 
used to make scaffolds.  Autologous vein grafts have been shown to provide a good 
environment for axonal regeneration in short nerve gaps [38,127].  However, use of vein 
grafts for long nerve gaps has been less successful, because of collapse of veins due to 
their thin walls, and constriction due to the surrounding scar tissue [22].  In order to 
prevent vein grafts from collapsing and improve their performance, intraluminal space 
fillers such as autologous Schwann cells, collagen, and muscle fibers have been used.  
Collagen-filled vein grafts were found to promote better axonal growth than empty vein 
grafts for a 15-mm nerve gap in rabbits [24].  Similarly, Schwann cell-seeded venous 
grafts supported axonal growth and performed better than unseeded grafts to repair 40 
mm nerve gaps [134] and 60 mm nerve gaps in rabbits [112].  The principal drawback of 
this approach is that it requires the availability of relevant amount of live autologous 
Schwann cells (up to 8 million cells/ml) that is difficult to obtain.  Muscle-vein combined 
grafts, in which the muscle fibers are inserted in veins, were used in 10-mm long nerve 
defects in rats, and found to promote axonal regeneration comparable to that of syngenic 
nerve grafts [41].  Although the muscle-vein grafts were able to promote nerve 
regeneration in 55-mm long nerve defects in rabbits, they were not comparable to nerve 
autografts [41].  Autologous muscle-vein combined grafts have been used clinically in 
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humans to bridge nerve gaps ranging from 5-60 mm.  The results were scored as “poor”, 
“satisfactory”, “good” and “very good”, based on recovery of sensory and motor 
functions.  Of the 21 lesions repaired (in 20 patients), 10 were lesions of the sensory 
nerves and 11 were mixed nerve lesions.  All lesions in the sensory nerves, except one 
greater than 30 mm, showed “good” to “very good” recovery.  All lesions in the mixed 
nerves showed “satisfactory” to “good” recovery of motor and sensory functions [10].  
Although autogenous/natural materials have shown encouraging results when 
used for nerve repair, they still have certain drawbacks.  In case of autogenous grafts, the 
drawbacks include the need for a second surgery, the loss of function at donor site, and 
neuropathic pain at donor site.  Allografts have problems related to preservation and 
immuno-rejection.  In order to avoid these problems, grafts made of artificial/synthetic 
materials have been used. 
 
1.8.2. Synthetic Scaffolds for Nerve Repair 
To overcome the problems associated with harvesting natural tissues, synthetic 
scaffolds have been developed.  Among the artificial materials, synthetic tubular NGCs 
have shown the most promising results so far (Figure 1-1).  The use of NGC reduces 
tension at the suture line, protects the regenerating axons from the infiltrating scar tissue, 
and directs the sprouting axons toward their distal targets.  The luminal space of NGCs 
can be filled with growth promoting matrix, growth factors and/or appropriate cells.  In 
some cases of nerve repair, NGCs have been used to intentionally leave a small gap 
between the injured nerve ends, to allow accumulation of cytokines, growth factors and 
cells [27].  The NGCs can be used as an excellent experimental tool, to control the  
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Figure 1-1: A schematic of a synthetic nerve guidance channel (NGC). 
The NGC, sutured to the nerve ends, is filled with one or more of the following 
components: hydrogel, filaments, cells, neurotrophic factors and ECM proteins.  
For an isotropic graft, there would be no filaments and the other components 
would be distributed uniformly. For an anisotropic graft, there may be 
filaments, and the other components would be aligned longitudinally or in 
inc reas ing concent ra t ion  f rom proximal  to  dis ta l  nerve end.  
 
 
distance between the nerve stumps, test the fluid and tissue entering the channel, and vary 
the properties of the channel [122].  
Nerve regeneration in silicone NGCs has been studied in detail [130], as 
described in section 1.4.  Briefly, following nerve repair using a NGC, a fibrin cable 
connecting the two nerve ends is formed within the NGC.  The fibrin cable is then 
invaded by cells migrating from the proximal and distal nerve stumps.  Axons from the 
proximal end grow into the fibrin matrix and are engulfed by the Schwann cells.  Some of 
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these axons then reach the distal nerve end and get myelinated.  In inert silicone tubes of 
10 mm or shorter, these processes occur spontaneously.  However, it is generally 
accepted that impermeable, inert NGCs such as silicone do not support regeneration 
across defects larger than 10 mm, without the presence of exogenous growth factors.  The 
regeneration process can be improved by various approaches like changing properties of 
the tube (permeability, roughness and electric charge characteristics), addition of matrices, 
neurotrophic factors, ECM molecules and cells [122]. 
Based on the porosity and/or degradability of the material used, NGCs can be 
classified as impermeable, semi-permeable and resorbable (Table 1-1).   
 
 
Table 1-1: Classification of NGCs based on porosity and degradability 
Porosity   Degradability   Example reference 
1. Impermeable  Non-degradable  Silicone 48 
2. Semipermeable             Non-degradable  PS 80, PAN/PVC 1, 71 




Porosity affects the movement of soluble factors, oxygen and waste products, 
through the walls of the NGCs, which is vital for nerve regeneration.  Silicone tube is an 
example of an impermeable NGC since it does not permit movement of molecules across 
the tube walls.  Examples of semi-permeable tubes are polysulphone (PS) and 
polyacrylonitrile/polyvinylchloride (PAN/PVC).  Nerves regenerated in semipermeable 
tubes featured more myelinated axons and less connective tissue, as compared to 
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impermeable NGCs [2,121].  PAN/PVC channels with a molecular weight cutoff of 50 
kilodaltons support regeneration even in the absence of a distal nerve stump [2].  
Examples of bioresorbable tubes are, polylactic acid (PLA), polyglycolic acid (PGA), 
poly(L-lactide-co-glycolide) (PLGA), poly-(lactide-co-caprolactone) (PLC) and poly(3-
hydroxybutyrate) (PHB).  The use of bioresorbable tubes negates the need for a second 
surgery to remove the implant and prevents long-term compression of the nerve.  
However, it is critical that the degradation of the tube should not allow fibroblasts to 
invade the lumen space before regeneration occurs, as this may prevent axons from 
regenerating.  
A wide variety of polymeric materials (polyethylene, silicone elastomers, 
polyacrylonitrile etc.), metals (stainless steel, tantalum etc.) and biological materials 
(artery, collagen, vein etc.) have been used to make these guidance channels 
[21,42,85,113].  In our study we have used polymeric guidance channels made of 
polysulfone (PS).  PS is a semi-permeable material having a molecular weight cut-off of 
50 kDa, which allows for controlled solute exchange between the internal regenerative 
and the external wound-healing environment, preventing connective tissue formation 
[2,121]. 
 
1.8.3. Polymer Guidance Channels Containing  3D Hydrogel Scaffolds 
Collagen gels 
Collagen gels and filaments have been used to promote PNS regeneration.  
Collagen gel can be used to fill the intra-luminal space of a vein graft to prevent it from 
collapsing and improve its nerve repair efficiency.  In collagen-filled vein grafts, the 
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number and diameter of myelinated axons was significantly increased compared to vein 
grafts without collagen gel [24].  Nerve repair with silicone tubes can be significantly 
improved by filling them with collagen gel.  Collagen tubes filled with collagen gel have 
promoted more rapid nerve sprouting, and better morphology, than saline-filled collagen 
tubes [106].  However, in some cases collagen gels have hindered regeneration as 
compared to saline-filled tubes [123].  In addition, collagen gels may be immunogenic 




Hyaluronic acid, an ECM component, is associated with decreased scarring and 
improved fibrin matrix formation.  It is hypothesized that during the fibrin matrix phase 
of regeneration, hyaluronic acid organizes the extracellular matrix into a hydrated open 
lattice, thereby facilitating migration of the regenerated axons [108].  Hyaluronan-based 
tubular conduits, used for peripheral nerve regeneration, resulted in more myelinated 
axons and higher nerve conduction velocities than silicone tubes filled with saline [128], 
with little cytotoxicity [60] upon degradation. 
Other gels used in vivo to promote nerve regeneration include Matrigel, alginate 
gels, fibrin gels and heparin sulphate gels [31,86,114] with mixed results. 
 
1.8.3.1. Agarose hydrogel is a potential biomaterial for bridging injured nerves 
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Agarose is a polysaccharide derived from red agar and is widely used in gel 
electrophoresis and gel chromatography.  SeaPrep® agarose hydrogel has been shown to 
support neurite extension from a variety of neurons in a non-immunogenic manner 
[11,30,73].  In addition, SeaPrep® agarose is thermo-reversible, making it easy to work 
with.  When heated to 65oC, SeaPrep® agarose hydrogels change to a liquid state and 
maintain this liquid state until cooled below 17oC, which results in the formation of gel.  
The gel-state is maintained until it is again heated above 65oC.  SeaPrep® agarose is 
transparent, allowing cells cultured in it to be easily observed by light microscopy.  
Agarose gels also allow molecules to be covalently linked to the gels through functional 
groups on its polysaccharide chains.  For example, laminin protein or fragments of 
laminin can be covalently coupled to SeaPrep® agarose gels to enhance their ability to 
support neurite extension [133].  Although agarose gels support neurite growth on their 
own, coupling of molecules, such as laminin, significantly enhances the gels’ ability to 
promote neurite extension.  Due to these reasons agarose gels have been used to promote 
nerve regeneration, both in vivo and in vitro.  0.5% (w/v) SeaPrep® agarose gel was 
reported to promote higher functional recovery than 1% and 2% SeaPrep® agarose gels in 
sciatic nerve injury model in rats, and no immunological response was observed [73,132].  
Hence we have used 0.5% SeaPrep® agarose gels for in vivo study.  However, 1% 
agarose gel was used for in vitro study because agarose gel with higher strength was 
needed for in vitro work.  
 
1.8.4. Polymer Guidance Channels with Neurotrophic Factors for Regeneration 
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Neurotrophic factors are produced by the target organs of nerves and help 
maintain the target organ-nerve synapse [59].  A nerve injury usually results in disruption 
of communication between the target organs and the neuronal cell body, and leads to 
Wallerian degeneration (breakdown of myelin sheath and axons).  Due to cytokines 
released during Wallerian degeneration, Schwann cells are activated and produce 
neurotrophins such as nerve growth factor (NGF) and brain-derived neurotrophic factor 
(BDNF).  Although many other trophic factors, including insulin-like growth factor (IGF), 
fibroblast growth factor (FGF) and ciliary neurotrophic factor (CNTF), have been shown 
to be involved in the promotion of nerve regeneration [43,45], it is believed that they are 
released from Schwann cells following mechanical damage to the cells.    
NGF is produced in the target organs of sensory and sympathetic nerves in the 
PNS, and has been shown to stimulate and promote the survival of sensory ganglia and 
nerves, including spinal sensory nerves and sciatic nerves [78,118].  BDNF is expressed 
in very low levels in intact adult peripheral nerves, but is upregulated following injury.  
BDNF is effective in promoting the survival and outgrowth of not only sensory and 
sympathetic nerves, but also motor nerves [109]. 
Neurotrophic factors will likely be an important part of future clinical therapies 
for peripheral nerve injuries/diseases.  Diseases in which the functions of Schwann cells 
are severely suppressed (Multiple Sclerosis, for example) or when acellular grafts 
(containing no viable Schwann cells) are used, delivery of neurotrophic factors could be 
highly effective in facilitating nerve regeneration.  Various studies have utilized the 
functions of NGF to promote nerve regeneration.  Hubble and Sakiyama-Elbert have 
developed a fibrin matrix that immobilizes heparin molecules by electrostatic interactions, 
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which in turn immobilizes heparin binding growth factors.  The fibrin matrix, when 
implanted in vivo, releases the bound growth factor due to fibrin degradation.  This 
system was used to deliver NGF [76] for peripheral nerve regeneration in vivo, and bFGF 
[104] for neurite extension from chick dorsal root ganglia (DRG) in vitro.  Fibrin-
heparin-NGF matrix was observed to promote nerve regeneration comparable to syngenic 
nerve grafts over a 13-mm nerve gap in rats.  Fibrin matrix that released bFGF enhanced 
neurite extension from DRG by 100% compared to unmodified fibrin matrix. 
 
1.8.4.1. Lipid-based Microtubules for slow-release of NGF 
 NGF has been shown to facilitate nerve regeneration across long nerve gaps [28].  
However, as neurotrophic factors have very short-half lives in vivo and are unstable in 
solution, controlled release systems are needed for their delivery [3,32].  For example, 
basic fibroblast growth factor released in a controlled manner significantly improved rat 
sciatic nerve regeneration across a 15-mm long gap [32].  In addition, slow release of 
growth factors can overcome the problem of “growth factor oasis” where neurites 
accumulate at high neurotrophic factor concentration regions in the scaffold. 
 Poly (ethylene-co-vinyl acetate) (EVAc) has been widely used for long-term 
release of NGF [55,71].  However, in this technique organic solvents are used for loading 
NGF into the EVAc polymer, and this loading process leads to dramatic loss of NGF 
activity [71].  To overcome this limitation, phosphatidylcholine based lipid microtubules 
have been developed for the delivery of bioactive agents [103,111].  Lipid microtubules 
are ideal for trophic factors because these sensitive proteins can be loaded into 
microtubules in an aqueous environment with no exposure to organic solvents.  Also, 
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because of their small dimension, the lipid microtubules can slowly release trophic 
factors without impeding neurite extension in co-culture with neuronal cells.  The lipid 
microtubules can also be fabricated in different lengths to vary the release profile of the 
trophic factor. 
 
1.8.5. Polymer Guidance Channels with ECM Molecules for Regeneration 
Insoluble ECM molecules, such as laminin, fibronectin and certain forms of 
collagen, promote axonal extension and therefore, are excellent candidates for 
incorporation into the lumen of NGCs.  Agarose gels crosslinked with laminin showed 
enhanced neurite extension from chick DRG in vitro [133].  Agarose gels crosslinked 
with laminin and soluble NGF showed nerve regeneration comparable to autografts over 
a 10 mm gap in rats [132].  However, axonal extension in the laminin gels depends on 
concentrations of laminin gels.  High concentrations of laminin hinder regeneration [74].  
Matrigel, a gel containing collagen type IV, laminin and glycosaminoglycans, supports 
some degree of regeneration over a long nerve gap in adult rats, when introduced into the 
lumen of NGCs [86].  Similarly, a gel mixture containing laminin, collagen and 
fibronectin, significantly improved nerve regeneration compared to saline-filled silicone 
NGCs [19]. 
 
1.8.6. Polymer Guidance Channels Pre-Seeded with Neuronal Support Cells for Nerve 
Regeneration 
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Performance of NGCs can be significantly improved by seeding the scaffolds 
with Schwann cells.  Apart from Schwann cells, genetically modified fibroblasts, 
olfactory ensheathing cells, bone marrow stromal cells, pluripotent stem cells from hair 
follicles have been used to promote nerve regeneration [6,23,80,95].  These techniques 
have been discussed in more detail in section 1.6.1. - 1.6.2., and will not be repeated here 
for brevity.  However, the difficulties of isolating and culturing these cells from the 
patient prior to surgery, could limit this approach for some surgical procedures.  
  
1.9. Challenges for the Design of Guidance Channels 
 In designing a polymer nerve guidance channel, its characteristics, such as, 
porosity, roughness, and electrical activity, can be modified to enhance its properties.  An 
ideal guidance channel should be biodegradable, should not elicit immune response, have 
electrical activity and be porous.  It should also be able to incorporate support cells, 
neurotrophic factors, and internal oriented matrices.  Also, it should be flexible, readily 
available and easy to fabricate [57].  
Up to the present, many techniques have been examined for enhancing peripheral 
nerve regeneration using guidance channels.  However, none of them have performed 
better than nerve autografts, the clinical “gold standard” for repairing nerve injuries.  
Even in cases where significant regeneration has been observed, it has been over short 
nerve gaps, about 10-mm nerve gaps.  However, in clinical applications for humans, there 
is a need to bridge nerve gaps greater than 10-mm.  Even in the best case of autografts, 
complete functional recovery is usually not achieved, due to misdirection of growing 
fibers, neuronal cell death, or atrophy/death of the denervated target organ [93,135].  
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Therefore, it is still a challenge to develop alternative approaches for enhancing 
peripheral nerve regeneration to the level comparable to autografts, and further to exceed 
the results obtained from autografts.   
 
1.10. Need for 3D Culture Models and Anisotropic Scaffolds  
1.10.1. Limitations of 2D tissue culture based models 
Most previous studies have examined the effects of sharp boundaries of laminin 
itself or laminin with other molecules to direct neurite outgrowth [35,89] in 2D cultures.  
Even in other studies which have examined the directionality of axonal elongation on 
gradients of substratum bound molecules, 2D cultures have been used [1,52,91].  
However, in vivo, the axons have to navigate a 3D ECM environment, and the changes in 
the LN concentration are more likely to be gradual than sharp.  The distribution of 
nutrients, substrate-bound molecules and cell-surface receptors in 3D cultures may be 
closer to in vivo conditions, as compared to 2D cultures.  Hence 3D cultures may mimic 
in vivo conditions better than 2D cultures.    
 
1.10.2. Limitations of Isotropic Scaffolds 
Currently, tissue engineered scaffolds using neurostimulatory molecules to 
promote nerve regeneration are isotropic in nature, that is, these molecules are distributed 
uniformly throughout the scaffold.  However, during development of nervous system, the 
molecules regulating neuronal migration (both permissive and inhibitory) are presented in 
spatially and temporally controlled fashion [12,13,110].     
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Neurotrophic factors have been delivered mostly in an isotropic manner in vivo. 
However, in vitro studies have suggested that gradients of neurotrophic factors can direct 
growth cones towards the source of neurotrophic factor [49].  Insoluble and soluble 
gradients of NGF, NT-3 and BDNF have been shown to direct the growth of neurites 
from PC12 cells toward increasing concentrations of neurotrophic factors [18,63].  
Therefore, anisotropic scaffolds having gradients of neurotrophic factors, along with 
other components might be an important tool for PNS regeneration.  
Gels containing ECM molecules, such as laminin, collagen, fibronectin and 
glycosaminoglycans, have been widely used to make isotropic scaffolds for nerve 
regeneration.  In vitro experiments with spatial patterns of whole ECM molecules [62] or 
their peptide derivates [105], have been used to direct the growth of neurites, as well as 
enhance neurite extension.  In vitro experiments have demonstrated that gradients of 
ECM proteins could orient and enhance neurite outgrowth toward increasing 
concentrations of ECM molecules [1,29].  However, this technique is yet to be utilized to 
enhance nerve regeneration in vivo, due to difficulties in making gradients of proteins in 
three-dimensional scaffolds. 
 
1.11. The Design and Significance of Our Study 
The objective of this research is to develop agarose-based 3D scaffolds to bridge a 
nerve gap induced by injury, and promote the regeneration of the transected nerves across 
a challenging nerve gap of 20-mm in rats.  The scaffolds have been incorporated with 
gradients of LN-1 and NGF to promote directional neurite extension of the regenerating 
axons.  The main hypothesis is: since neurons use gradients of neuro-stimulatory and 
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inhibitory cues for neurite extension and target finding during development and 
regeneration, such gradients will be suitable for stimulating peripheral nerve regeneration 
in adult animals.  Hence, a spatially and temporally controlled presentation of neurite 
growth promoting molecules, NGF and LN-1, might lead to enhanced regeneration.   
  
1.11.1. Design a novel anisotropic agarose hydrogel based 3D scaffolds to stimulate 
directional neurite extension in vitro. 
In this study we propose the design of an agarose hydrogel-based 3D scaffold 
with increasing concentrations of ECM protein, LN-1, to stimulate and direct the growth 
of neurite in vitro.  The hypothesis is that anisotropic 3D agarose hydrogel scaffolds with 
gradients of LN-1 will promote longer and faster neurite extension than isotropic 
scaffolds with uniform concentrations of LN-1.  
In the current study, we propose that a diffusion model can be used to create 
gradients of laminin molecules in porous agarose hydrogels.  The LN-1 molecules can 
then be photo-immobilized within the agarose matrix to create immobilized gradients of 
LN-1.  Isotropic LN-1 scaffolds, with uniform concentrations of LN-1 coupled to agarose 
hydrogel, have shown enhance neurite extension from primary chick dorsal root ganglia 
(DRG) and PC 12 cells [132].  In our current study, we would like to test if anisotropic 
scaffolds can promote longer and more oriented neurite extension, as compared to the 
isotropic scaffolds.  Enhanced neurite extension using anisotropic scaffold will lead to 
design of better scaffolds for axonal regeneration in vivo.    
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1.11.2. Enhance nerve regeneration across a 20-mm long nerve gap in adult rats using 
anisotropic agarose-based scaffolds  
 In this study we propose the design of an agarose-based scaffold with increasing 
concentrations of two neurostimulatory molecules, LN-1 and NGF, to enhance nerve 
regeneration across a challenging nerve gap of 20-mm in rodents.  
 Polysulfone NGCs containing agarose hydrogel scaffolds will be used to bridge 
nerve gaps in rats.  Immobilized gradients of LN-1 will be created in the agarose 
hydrogels by photochemical conjugation.  Lipid-based microtubules (LMTs)-loaded with 
NGF will be embedded within these agarose scaffolds to slow-release NGF.  A variable 
loading of LMTs into the agarose scaffold will be used to generate a diffuse gradient of 
NGF in the scaffolds.  Thus, our anisotropic scaffolds will have gradients of both LN-1 
and NGF, two important neurostimulatory molecules, to mimic in vivo conditions.   
 
1.12. Animal Models for Nerve Regeneration 
Traditionally, nerve regeneration studies have involved the use of various animal 
models, such as mice, rat, pigs, dogs, sheep and non-human primates.  Rat or mice 
models are used initially to determine the efficacy of the various treatments.  If the results 
are encouraging, they are followed by experiments with larger animal models.  For PNS 
regeneration studies, the most commonly studied nerve models are the sciatic nerve and 
its branches, the tibial and the peroneal nerves.  Other models include the cavernous 
nerve, femoral nerve and the facial nerve.  The most common nerve injury model is the 
single-anastomosis model where the injury and repair are done on one sciatic nerve and 
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the contralateral sciatic nerve is used as a control.  This model is useful when the nerve 
gap is not more than 20-mm. The second version is the cross (double) anastomosis model, 
where both ipsilateral and contralateral sciatic nerves are transected; the proximal end of 
the right sciatic nerve is then sutured to one end of an implanted tube and the distal end of 
the left sciatic nerve is inserted into the other end of the tube [84].  This model allows the 
study of gaps in excess of 25-mm.  Although very convenient, the rodent models suffer 
from the serious drawback that they present only short nerve gaps for regeneration 
studies.  In order for a regeneration technique to be successfully applied in clinical trials, 
the nerve gap model has to be more than 40 mm in length.  To create a long nerve gap 
model, rabbits [41], cats [114], dogs [88], sheep [75] and non-human primates [4] have 
been used.  The large animal models are an important intermediary step before clinical 
application of experimental therapeutic approaches.  
 
1.13. Conclusions 
In spite of significant advances in research to the development of synthetic NGCs, 
nerve autografts are still considered the first-choice strategy for nerve repair, especially in 
the case of long nerve gaps.  However, complete functional recovery is seldom observed 
with autografts.  Using autografts generally results in a good recovery of sensory 
functions but negligible return of motor functions.  Also, autografts have limited 
availability. Hence, there is lot of interest in developing synthetic nerve guidance 
channels as alternatives to autografts.  The properties of guidance channels can be readily 
modified to enhance its function.  Moreover, guidance channels can be incorporated with 
cells, neurotrophic factors, ECM proteins, and scaffolds, to enhance its performance.  
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However, guidance channels still have not been able to match the performance of 
autografts.  Ongoing rapid advances in cell biology, cell culture techniques, genetic 
engineering and biomaterials research, are likely to provide new tools to improve 
regeneration using NGCs, and the day an engineered construct performs as well as 
autografts may be near. 
In order to improve upon the performance of nerve guidance channels, we 
propose the design of a novel agarose-based 3D scaffold with directional cues for 
regeneration in vivo.  New techniques to create immobilized gradients of LN-1, and 
diffuse gradients of NGF have been proposed.  These scaffolds will create regenerative 
conditions around the injured axons that are closer to physiological conditions.  These 
scaffolds do not use cells, and hence are easy to fabricate and implant in vivo.  If 
successful, these scaffolds may provide a significant advance in our efforts to promote 
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Chapter 2:  ANISOTROPIC SCAFFOLDS FACILITATE ENHANCED NEURITE 
EXTENSION IN VITRO 
This work has been published in Journal of Biomedical Materials Research, Aug, 2006; 
78(2):213-21. 
 
Tissue engineering (TE) techniques to enhance nerve regeneration following 
nerve damage have had limited success in matching the performance of autografts across 
short nerve gaps (< 10mm).  For regeneration over longer nerve gaps, TE techniques have 
been less successful than autografts.  Most engineered scaffolds do not present directional 
cues to the regenerating nerves.  In our efforts to find a TE scaffold to replace the 
autograft, we hypothesize that anisotropic hydrogel scaffolds with gradients of a growth 
promoting glycoprotein, laminin-1 (LN-1), may promote directional neurite extension 
and enhance regeneration.  In this study we report the engineering of three-dimensional 
(3D) agarose scaffolds with photoimmobilized gradients of LN-1 of differing slopes.  
Dorsal root ganglia (DRG) from chicken embryos were cultured in the agarose scaffolds 
and their neurite extension rate was determined.  DRG neurite extension rates were 
significantly higher in the anisotropic scaffolds, with a maximal growth rate in an 
anisotropic scaffold twice that of the maximal growth rate in isotropic scaffolds of LN-1.  
We suggest that these anisotropic scaffolds, presenting an optimal gradient of LN-1, may 
significantly impact nerve regeneration.  Such anisotropic scaffolds may represent a new 





Injuries to the nervous system can lead to loss of sensory and motor functions and 
result in debilitating diseases.  In cases where the peripheral nerve is damaged, 
techniques to repair damaged peripheral nerves include coaptation by suturing the two 
ends of a severed peripheral nerve together.  When the gaps are large, autografts are used 
as the bridge materials.  However, gaps greater than 3 mm cannot be repaired through 
coaptation and procuring autografts is often difficult due to lack of availability.  This has 
necessitated the pursuit of alternatives to the use of autografts [132,151].  One such 
alternative approach is to design a 3D scaffold containing growth-promoting extracellular 
matrix (ECM) proteins, such as laminin-1 (LN-1), to promote peripheral nerve 
regeneration [107,163].  Laminins (LN) are a family of ECM-bound glycoproteins found 
in basement membrane of most tissues, and are expressed in developing nervous system 
as well as the adult peripheral nervous system (PNS) [120].  Several studies have shown 
LN as potent promoters of neurite growth in several types of cultured neurons 
[13,124,126], as directional cues for axonal growth in vitro [1,32,39,66], and as important 
guidance molecules for steering and path-finding for developing axons in vivo [17,53].   
The ability of LN to stimulate neurite outgrowth in vitro, along with the known 
role of LN in the developing nervous system [79,135], has led to the hypothesis that LN 
will contribute positively to peripheral nerve regeneration after injury.  Even though 
regeneration in the PNS is more extensive than regeneration in the central nervous system 
(CNS), successful regeneration over large nerve gaps in the PNS is rare.   
During development, the guidance of growth cones to their target tissues is 
mediated by multiple factors, such as chemoattractant, chemorepellant, contact-attractive 
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and contact-repulsive molecules [143], and some of these growth cone guidance cues 
may be distributed in a graded fashion [16].  There is considerable evidence for gradients 
of soluble factors orienting the locomotion of non-neuronal cells and growth 
cones.[25,93]  Although the influence of gradients of soluble substances on neuronal 
behavior has been extensively studied and has been used to unravel the molecular and 
cellular mechanisms of axonal guidance [135], much less is known about gradients of 
substratum bound substances [11], such as LN.  We hypothesize that anisotropic 
scaffolds presenting a gradient of LN may enhance neurite extension relative to isotropic 
scaffolds, potentially leading to higher success rates in large nerve gap regeneration. 
Since, appropriate substrate-bound and diffusible agents can influence nerve 
growth, biomaterials can be used to manipulate physical, chemical and biological cues 
around the injured neurons to control cellular responses and facilitate regeneration.  
Agarose is a polysaccharide derived from red agar, and is widely used in gel 
electrophoresis and gel chromatography.  SeaPrep® agarose solutions gel at a low 
temperature (17oC) and are capable of thermo-reversibly changing back to liquid state 
when heated above 50oC.  Therefore once gelled, it remains gel at physiological 
temperatures.  SeaPrep® agarose gel is transparent allowing cells cultured in it to be 
easily viewed under microscope.  SeaPrep® agarose has many functional groups, which 
can be modified to attach proteins and other molecules to it.  SeaPrep® agarose hydrogels 
have been shown to support neurite extension from a variety of neurons in a non-
immunogenic manner [15,40,41,164].  Agarose gels also allow various molecules to be 
covalently linked to the gels through various functional groups on the polysaccharide 
chains.  For example, LN-1 peptides or the full protein can be covalently coupled to 
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SeaPrep® agarose gels to enhance their ability to support neurite extension [164].  
Although agarose gels support neurite growth on their own, coupling of LN-1 
significantly enhances the gels’ ability to promote neurite extension.  This makes agarose 
hydrogel a suitable 3D matrix for culturing neurons.  
In this study we report the fabrication of anisotropic three-dimensional (3D) 
agarose hydrogel scaffolds with gradients of coupled LN-1 and examine the effects of 
these gradients of LN-1 on neurite extension in 3D.  We suggest that these scaffolds 
represent a new generation of tissue engineered scaffolds with built in directional cues for 
enhanced nerve regeneration.   
 
2.2. Materials and Methods 
2.2.1. Generation of isotropic and anisotropic 3D hydrogel scaffolds 
2.2.1.1. Isotropic LN-1 scaffolds generated using photochemistry  
Photochemical coupling was used to immobilize soluble, photosensitive LN-1 
conjugate.[23]  LN-1 (BD Biosciences, Bedford, MA) was coupled to the agarose 
scaffold using a photocrosslinker, Sulfo-SANPAH (Sulfosuccinimidyl-6-[4’-azido-2’-
nitrophenylamino] hexanoate) (PIERCE, Rockford, IL).  Sulfo-SANPAH is a hetro-
bifunctional crosslinker with a Sulfo-NHS group, that chemically reacts with amine 
groups, and a photoreactive perfluoro arylazide group that replaces the hydrogen atom in 
C-H bonds when triggered with UV light, [149] as schematically depicted in Figure 2-1.  
When added to an aqueous solution containing LN-1, Sulfo-SANPAH immediately 
hydrolyzes and its reactive groups are exposed.  The Sulfo-NHS group reacts with the 










Figure 2-1: Schematic of photocrosslinking chemistry. LN-1 first reacts with 
Sulfo-SANPAH via its amine group. The LN-1-SANPAH conjugate is exposed 
 to UV light, activating SANPAH and initiating reaction with C-H bonds in the 
aga rose  backbone  re su l t ing  in  the  c ross l ink ing  o f  LN-1  to  aga rose . 
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conjugate is added to an agarose solution and exposed to UV light, the perfluoro 
arylazide group of SANPAH facilitates the coupling of LN-1 to agarose, which has an 
abundance of C-H bonds.  Briefly, SANPAH was weighed and added to a solution of 
LN-1 in phosphate buffered saline (PBS; pH 7.4) solution so that SANPAH: LN-1 molar 
ratio is 100:1.  The mixture was incubated with stirring at 500 RPM for 4-5 hrs at 4oC to 
allow conjugation of SANPAH with LN-1.  The LN-1-SANPAH conjugate was dialyzed 
against PBS using Spectrum® dialysis blocks (MWCO 10 kDa, Spectrum Lab Inc., 
Rancho Dominguez, CA) to remove unreacted SANPAH molecules.  To this conjugate 
solution, an equal volume of 2% (w/v) SeaPrep® agarose (BMA, Rockland, ME) solution 
was added.  Agarose solution was prepared by dissolving agarose in PBS solution (pH 
7.4) by heating at 60oC and stirring until the solution became clear.  The resulting 1% 
(w/v) agarose scaffold with LN-1-SANPAH conjugate was then exposed to UV light 
from a BP-100AP lamp (100W, 365nm, 12.5 mW/cm2 at a distance of 3”, UVP, Upland, 
CA), held 3” from the sample, for 60 seconds, to trigger the coupling of LN-1 to the 
agarose solution via the SANPAH photocrosslinker.  The solution was then allowed to 
gel by cooling it at 4oC for 20 minutes.  Unbound LN-1 was removed from the gel by 
washing with PBS solution, with repeated changes, for 2 days.  The gel was then heated, 
below 40oC, de-gelled and the amount of LN-1 coupled to the gel was determined by 
Bradford protein assay (BIO-RAD, Hercules, CA).  As a control, agarose gel mixed with 
LN-1 (no SANPAH) was used under conditions identical to those for coupling SANPAH-
LN-1.   
 
2.2.1.2. Determination of efficiency of coupling LN-1 to agarose scaffold 
 48
In order to test the efficiency of photochemical coupling of LN-1 to agarose, 
different concentrations of LN-1-SANPAH conjugate were mixed with agarose solutions 
so as to obtain 1% (w/v) agarose solutions with a range of LN-1 concentrations - 85 
µg/ml, 113.33 µg/ml and 170 µg/ml.  These solutions were then exposed to UV light, at 
3” from the UV lamp, for 60 seconds.  The solutions were then allowed to gel by cooling 
at 4oC for 20 minutes.  As a control, agarose scaffold mixed with LN-1 (no SANPAH) 
was used under conditions identical to those for coupling SANPAH-LN-1.  The scaffolds 
were then washed with PBS solution for 2 days to remove any unbound LN-1.  The 
amount of LN-1 coupled to these scaffolds was determined by Bradford protein assay. 
 
2.2.1.3. Generation of anisotropic LN-1 concentrations in 3D agarose hydrogels  
Eight-well chamber slides (Fisher Scientific, Pittsburg, PA) were used for making 
anisotropic LN-1 scaffolds and for culturing chick DRG ganglia.  A 2.5 mm thick block 
of agarose hydrogel was formed in each well of the chamber slide by adding 1% (w/v) 
agarose solution between two custom-built teflon bars separated by a distance of 2.5 mm 
(Figure 2-2A).  The chamber slide was placed at 4oC for 20 minutes to allow the agarose 
solution to gel.  After the agarose gelled, the teflon bars were removed and the well was 
divided into two compartments by the agarose scaffold. 
To visualize LN-1 gradient in agarose scaffold, LN-1 molecule was labeled with a 
fluorescent molecule, rhodamine, using EZ-Label Rhodamine protein labeling kit 
(PIERCE, Rockford, IL).  One of the compartments was filled with 100 µl of LN-1- 









Figure 2-2: Schematic of experimental setup for gradient studies and DRG cultures. 
(A) To synthesize and characterize anisotropic LN-1 scaffolds an agarose scaffold 
block was prepared in the middle of a slide chamber well. LN-1 solution was 
added in the compartment marked “high” and PBS solution was added in the 
compartment marked “low”. (B) For studying neurite extensions in LN-1 
gradients, DRG were first mixed with agarose and then the LN-1 gradient was made. 
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Figure 2-2A) and the other compartment was filled with 100 µl of PBS solution with no 
LN-1 (henceforth referred to as the “low” concentration compartment, Figure 2-2A).  The 
scaffolds were then stored in an incubator at 37oC and 95% humidity for 6 hours and LN-
1 was allowed to diffuse through the agarose scaffold from the “high” concentration 
compartment to the “low” concentration compartment.  After 6 hours, the solutions from 
the two compartments were removed and the scaffold block was immediately exposed to 
UV light from a BP-100AP lamp (12.5 mW/cm2 at a distance of 3 inches) for 60 seconds 
to photoimmobilize LN-1-rhodamine.  Uncoupled rhodamine-LN-1 was removed by 
washing the agarose scaffold block with PBS solution for 2 days.  To test whether LN-1 
was coupled to the scaffold in a gradient fashion, fluorescent images were captured using 
MicroFireTM digital camera (Olympus, Melville, NY) attached to an upright microscope 
(Model Axioskop 2, Carl Zeiss Inc., Germany).  Images were taken at 3 different depths 
within the scaffolds, to check for uniformity of coupling through the thickness of the gel. 
The fluorescence intensity of the images was measured using ImageProTM software 
(OPTRONICS, Coleta, CA).  A relationship between fluorescence intensity and 
rhodamine-LN-1 concentrations was obtained by mixing known concentrations of 
rhodamine-LN-1 in 1% agarose scaffold and then measuring its fluorescence intensity. 
 
2.2.2. Determining response of chick dorsal root ganglia neurites to LN-1 gradients 
DRG culture in agarose hydrogel 
Dorsal root ganglia (DRG) were harvested from 9-day old chicken embryos (E9) 
into PBS solution.  Each DRG explant was split into 2-3 pieces and suspended in 1% 
agarose solution.  An agarose scaffold block containing DRG was made as described 
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above for plain agarose (Figure 2-2B).  LN-1 solution diluted in Dulbecco’s Modified 
Eagle Medium (DMEM) was added to the “high” concentration compartment and DMEM 
by itself was added to the “low” compartment.  LN-1 was allowed to diffuse through the 
agarose scaffold for 6 hours to form a LN-1 gradient.  The hydrogel was then exposed to 
UV light for 60 seconds at a distance of 3 inches.  DMEM with 10% fetal bovine serum 
(FBS), 1% penicillin-streptomycin (PS) and 50 ng/ml nerve growth factor (NGF) was 
added to each of the wells.  The cultures were then maintained at standard cell culture 
conditions of 37oC, 5% CO2 and 95% humidity for 4-5 days.  Neurite extension from DRG 
was visualized using an inverted microscope (Model Axiovert 200M, Carl Zeiss Inc., 
Germany).  The lengths of specific, marked neurites were quantified on day 2, day 3 and 
day 4 of culture to help determine the rate of neurite extension.  Extreme care was taken to 
measure the length of the same neurites for these measurements, using appropriate 
landmarks in the culture dish.  The choice of neurites was not random, however, the 
longest neurites were identified by measuring their lengths at day 2, and subsequently 
these neurites were followed until day 4 of culture.   
To test the influence on neurite outgrowth due to gradients of LN-1 as compared 
to uniform concentrations of LN-1, three conditions were studied.  DRGs were cultured 
in 3D scaffolds with either uniform concentrations of LN-1 (0.2, 0.5, 0.8, 1.02, 3.4 and 
10.21 µg/ml) or gradients of LN-1 (0.017 µg/ml/mm, 0.051 µg/ml/mm and 0.121 
µg/ml/mm) or plain agarose (0 µg/ml).  Neurites were considered as growing “up the 
gradient” when the angle (α) between the line connecting the point where it emerged 
from the DRG and the tip of the neurite, and the line following the steepest increase in 
the concentration of LN-1 (∆laminin = maximum in Figure 2-3) was such that -55o < α < 
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Figure 2-3: Schematic of an axonal process on a LN-1 gradient and 
how the angle α is defined. The neurites are considered as growing “up 
the gradient” if -55o < α < -55o, “down the gradient” if -125o < α < 
125o, and “perpendicular to the gradient” if 55o < α < 125o and -125o < 










55o.  The 55o angle was selected because the neurites that grew within ± 55o experienced 
50% of the maximum slope of change in LN-1 concentration (∆laminin) of that gradient.  
The neurites were considered as growing “perpendicular to the gradient” if 55o < α < 125o 
and -125o < α < -55o; and neurites were considered as growing “down the gradient” if 
they were extending in the direction of decreasing concentration of LN-1 (125o < α < -
125o).  A schematic illustration of these definitions is shown in Figure 2-3.  One-way 
ANOVA test was used for statistical analysis and a p-value of less than 0.05 was 




2.3.1. Characterization of 3D hydrogels with controlled, anisotropic LN-1 concentrations  
2.3.1.1. Generation of isotropic LN-1-agarose scaffolds  
Increasing the amount of LN-1-SANPAH conjugate initially added to the agarose 
solution led to proportionally higher amounts of LN-1 being coupled to the agarose 
scaffold (Figure 2-4).  When the amount of LN-1 initially added to agarose scaffold was 
doubled from 85 µg/ml to 170 µg/ml, the amount of LN-1 coupled to the scaffold 
increased more than three times (from 8.07 to 26.02 µg/ml) suggesting that the 
relationship between the amount of LN-1 added and amount of LN-1 coupled to scaffold 
is non-linear.  The coupling efficiencies ranged from 9.5% (w/w) for the 85 µg/ml LN-1-
agarose solutions to 15.3% (w/w) for the 170 µg/ml LN-1-agarose solutions (Figure 2-4). 
The coupling efficiencies for 133.33 µg/ml (13.41%) and 170 µg/ml (15.31%) were not 
significantly different (as compared by student’s paired t-test).  This suggests that the 
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coupling efficiency had saturated at around 15% (w/w) for the range of LN-1 
concentrations used in our study. 
 
 
Figure 2-4: Photochemical immobilization of isotropic LN-1-concentrations in 
agarose scaffolds. Note that the concentration of LN-1 coupled to agarose scaffold 
increased when higher concentrations of LN-1 were added. The percentage of LN-1 
coupled to agarose also increased with concentration but saturated around 15.31%.  
* represents p < 0.05 vs. 85 µg/ml data, # represents p < 0.05 vs. 133.33 µg/ml data; 
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Figure 2-5: Concentration profile of LN-1-rhodamine bound to agarose scaffold. The gradient 
shown here was obtained when 282 µg/ml of LN-1 solution was added to the “high” compartment 
and PBS was added to the “low” compartment. The concentration profiles in the direction along 
(Figure 2-5B) and perpendicular (Figure 2-5C) to the gradient were obtained by averaging 
intensity profiles from 3 images at different depths from the same scaffold block. In Figure 2-5C, 
the dark line indicates the average concentration, gray lines indicate standard deviations from the 
average values, and the red line indicates the polynomial fit to the average concentration profile. 




Agarose scaffold with  
LN-rhodamine 
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2.3.1.2. Characterization of LN-1 gradients in agarose scaffolds 
Anisotropic LN-1 scaffolds with three different concentrations ranges, 0.430- 
0.126 µg/ml, 0.250- 0.123 µg/ml and 0.162- 0.120 µg/ml, having different slopes of LN-
1 concentration gradients, 0.121 µg/ml/mm, 0.051 µg/ml/mm and 0.017 µg/ml/mm, 
respectively, were obtained by adding different concentrations of LN-1 in the “high” 
compartment.  Figure 2-5 depicts the distribution of immobilized rhodamine-LN-1 across 
a 2.5 mm wide agarose scaffold block along the direction of gradient (Figure 2-5B) and 
also perpendicular to the gradient (Figure 2-5C).  This LN-1 distribution was obtained 
when a 282 µg/ml LN-1 solution was added to the “high” concentration compartment of 
the scaffold and PBS solution was added to the “low” concentration compartment.  
Immobilization by UV light was done after 6 hours of diffusion.  An average intensity 
profile was obtained by taking fluorescence intensity images at three different, fixed 
levels within the same agarose scaffold block and averaging the intensity values.  The 
LN-1 distribution in the anisotropic scaffolds could be approximated by a second-order 
polynomial as shown in Figure 2-5B.  
  
2.3.2. Neurite growth from DRGs cultured in gradients of LN-1 
2.3.2.1. Neurite extension in isotropic LN-1 scaffolds 
Three culture wells were used for DRG culture for each of the different isotropic 
LN-1 concentration scaffolds: 0, 0.2, 0.5, 0.8, 1.02, 3.4 and 10.21 µg/ml.  For each 
condition, images of DRGs and their neurites were captured on day 1, day 2, day 3 and 
day 4.  Around 30-35 neurites from each of 5-6 different DRGs, which could be reliably 
followed over the 4 days of culture, were chosen for growth rate measurements.  The rate 
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Figure 2-6: Neurite growth rate data from DRG explants in LN-1-agarose 
scaffolds. (A) Neurite growth rate in anisotropic LN-1 scaffolds. One-way 
ANOVA was performed for n = 30-35 neurites/group. * indicates p-value 
< 0.05 compared to neurites growing “down the gradient”, # indicates p-
values < 0.05 compared to neurites growing “perpendicular to the gradient”. 
(B) Neurite growth rate in isotropic LN-1 scaffolds with different LN-1 
concentrations.  All error bars indicate standard error of mean (SEM).  
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of neurite extension was calculated by measuring neurite lengths at different time points.  
Care was taken to see that the length of the same neurite was measured at different time 
points by using fixed landmarks in the culture well.  Maximum neurite growth rate was 
found for the LN-1 concentration range of 0.2-0.5 µg/ml.  The rate decreased at higher 
LN-1 concentrations (Figure 2-6B). 
 
2.3.2.2. Neurite extension in anisotropic LN-1 scaffolds    
DRG neurite growth rate in three different LN-1 gradients: 0.121 µg/ml/mm 
(from 0.430- 0.126 µg/ml, over 2.5 mm thick agarose scaffolds), 0.051 µg/ml/mm (from  
0.250 µg/ml - 0.123 µg/ml) and 0.017 µg/ml/mm (from 0.162 µg/ml - 0.120 µg/ml) 
(Figure 2-6A), was determined similar to isotropic LN-1 culture conditions.  In all the 
three LN-1 gradients, similar initial concentration of LN-1 for the lower end was applied 
(around 0.120 µg/ml), so that the neurites were exposed to identical initial concentration 
of LN-1.  The number of neurites and DRGs considered for rate measurements were 
identical to the isotropic LN-1 scaffold conditions.  The neurite growth rate was highest 
for the lowest slope of LN-1 gradient, 0.017 µg/ml/mm.  As the slope of the LN-1 
gradient was increased, the neurite growth rate decreased.   
For 0.017 µg/ml/mm gradient, neurites growing “up the gradient” grew 
significantly faster than neurites growing “down the gradient” (p < 0.01), which in turn 
grew faster than neurites growing “perpendicular to gradient” (p < 0.05).  For 0.051 
µg/ml/mm gradient, neurites grew “up the gradient” significantly faster than neurites 
growing “down the gradient” and neurites growing “perpendicular to the gradient”, but 











Figure 2-7: DRG cultured in anisotropic LN-1-agarose scaffolds. (A) plain agarose, 
(B) 0.017 µg/ml/mm (C) 0.051 µg/ml/mm and (D) 0.121 µg/ml/mm scaffold. The white 
arrow indicates the direction of increasing concentration of LN-1 (Scale bar = 100 µm).
Plain agarose (A) and 0.121 µg/ml/mm scaffolds (D) promoted neurite extension 
uniformly in all directions, whereas 0.017 µg/ml/mm (C) 0.051 µg/ml/mm scaffolds 










“perpendicular to the gradient”.  For 0.121 µg/ml/mm gradient, there was no significant 
difference between growth rate of neurites growing “up the gradient”, “down the 
gradient” and “perpendicular to the gradient”.  Representative phase-contrast microscopy 
images of DRG cultured in the anisotropic scaffolds and plain agarose have been shown 
in Figure 2-7.   
Figure 2-8: Comparison of neurite growth rate between anisotropic and 
isotropic LN-1 scaffolds using one-way ANOVA. * indicates p-value < 0.01 
compared to “up the gradient” group, # indicates p-value < 0.01 compared to 
“down the gradient” group. The numbers in the bracket for 0.017 µg/ml/mm 







The best neurite growth rate in anisotropic scaffolds was compared to the best 
neurite growth rate in isotropic scaffolds (Figure 2-8).  Fastest neurite growth rate in 
anisotropic scaffolds was at a LN-1 gradient of 0.017 µg/ml/mm (0.120 µg/ml – 0.162 
µg/ml) and in isotropic scaffolds was at 0.5 µg/ml LN-1 concentration.  In anisotropic 
scaffold neurite extension “up the gradient” (27.8 µm/hr) and “down the gradient” (18.2 
µm/hr) were significantly faster than neurite extension in 0.5 µg/ml isotropic LN-1 
scaffold (14.38 µm/hr). 
In order to test if LN-1 gradients orient the direction of neurite outgrowth, the 
total number of neurites growing “up the gradient”, “down the gradient” and 
“perpendicular to the gradient” were counted for each culture condition.  No significant 
differences between these numbers were observed for any of the conditions.  It was also 
noticed that the neurite which had started growing “down the gradient” or “perpendicular 
to the gradient” did not try to reorient itself “up the gradient”, but continued growing 




A technique to generate diffuse gradients of nerve growth factor (NGF) in 3D 
scaffolds has been previously described by Cao et al.[23] As a strategy to promote 
regeneration across long gaps, immobilized gradients may be more sustainable than 
diffuse gradients over the period of several weeks during which PNS regeneration occurs.  
This study presents a technique to fabricate anisotropic 3D scaffolds with immobilized 
gradients of LN-1 and quantitatively evaluates the influence of these scaffolds on chick 
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DRG neurite extension.  Isotropic LN-1 scaffolds and plain agarose scaffolds without 
LN-1 were used as controls.  The results demonstrate that particular concentration 
gradients of LN-1 promote faster neurite extension than the highest neurite growth rate 
observed with isotropic LN-1 concentrations.  This suggests that gradients of LN-1 may 
be a more important parameter to optimize for maximal neurite extension rather than the 
absolute concentrations of isotropically distributed LN-1.  The highest growth rate 
observed in anisotropic scaffolds was almost 5-times the growth rate in plain agarose gels.  
When DRGs were cultured in anisotropic LN-1 scaffolds with a steep slope of LN-1 
gradient (0.121 µg/ml/mm or 241% concentration difference across 2.5 mm scaffold), 
there was no difference in neurite growth rate “up the gradient”, “down the gradient” and 
“perpendicular to gradient”.  When the steepness of the gradient was reduced to 0.051 
µg/ml/mm (103.3% concentration difference across 2.5 mm scaffold), there was 
difference between neurite growth rate “up the gradient” and “down the gradient” (p-
value < 0.05).  When the steepness of the gradient was further reduced to 0.017 
µg/ml/mm (or 35% concentration difference across 2.5 mm scaffold), there was even 
more difference between neurite growth “up the gradient” and “down the gradient” (p-
value < 0.01).  
LN-1 is an appropriate candidate as the protein of choice for PNS regeneration 
since it has been shown to be a potent stimulator of neuronal cell migration and neurite 
outgrowth [13,124,126].  The spatio-temporally controlled expression of LN-1 in the 
developing peripheral nervous system, as well as the visual pathway and the cerebellum, 
suggests that LN plays a role in axon outgrowth and guidance [99,111,125].  LN 
expression has been found to be essential for ventral turning of axons during 
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development.  Blocking nidogen-binding motifs on LN prevents turning of axons 
although it does not affect growth [17], indicating that LN might play a role in orientation 
of axons in some systems.   
Most previous studies have examined the effects of sharp boundaries of LN itself 
or LN with other molecules to direct neurite outgrowth [47,108] in 2D cultures.  Even in 
other studies which have examined the directionality of axonal elongation on gradients of 
substratum bound molecules, 2D cultures have been used [1,66,110].  In our study we 
have used a 3D culture model with immobilized gradients of LN-1, which may be of 
greater physiological relevance as, in vivo, the axons have to navigate a 3D ECM 
environment, and the changes in LN concentrations are more likely to be gradual than 
sharp.  Previous studies have examined the directionality of axonal elongation on 
gradients of substratum-bound molecules.  McKenna et al. have shown that growth cones 
of sympathetic neurons show no directional response to substratum-bound laminin 
gradient [110]. On the other hand, Halfter has shown that elongation of retinal axons was 
affected by gradients of merosin (laminin-2) or a basal lamina extract [66].  Axons 
growing down a gradient were shorter and more fasciculated, while axonal turning was 
noted for axons growing up a shallow gradient.  Adams et al. have reported that axonal 
growth cones can turn and migrate up a substratum-bound gradient of peptide from the 
LN-1 α1 chain on 2D substrates [1].  But once the growth cones were oriented along the 
gradient, whether “up the gradient” or “down the gradient”, they grew rapidly in either 
direction. In the anisotropic scaffolds used in our studies, the extending neurites were 
exposed to either increasing or decreasing gradient of LN-1.  The neurites that were 
exposed to decreasing gradient did not try to reorient themselves “up the gradient”, but 
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continued to grow “down the gradient”.  Similarly, neurites exposed to increasing 
gradient of LN-1 did not try to reorient themselves “down the gradient”.  However, the 
steepness of the gradients influenced the rate of neurite extension, as described earlier in 
this section. In this study, the steepest gradient of 0.121 µg/ml/mm yielded a 2.41% 
concentration change across 25 µm, which is the mean diameter of a growth cone. In the 
0.051 µg/ml/mm gradient, there was a 1.03% concentration change across the growth 
cone, and in the 0.017 µg/ml/mm gradient, there was a 0.35% concentration change 
across the growth cone. The percentage of change in concentration across the growth 
cone, at which we observed differences in neurite growth rates in these studies, was 
generally lower than that used by other studies (10% by Adams et al., and 3.5% by 
McKenna et al.). However, the amounts of LN-1 in gradients used in this study were 
generally higher compared to the above mentioned studies, which could have enhanced 
our ability to observe changes in the neurite growth rates.  Interestingly, it was observed 
that when the steepness of LN-1 gradients (consequently the % change in concentration 
across growth cone) was decreased from 0.121 µg/ml/mm (2.41%) to 0.051 µg/ml/mm 
(1.03%) to 0.017 µg/ml/mm (0.35%), the neurites growth rate increased, and the rate of 
neurite growth “up the gradient” was faster than rate of neurite growth “down the 
gradient”.  This could be due to regulation of receptors for LN-1 by chick DRG. Condic 
et al. have shown that chick DRG down-regulate receptors for LN-1 when cultured in 
high concentrations of LN-1 and up-regulate the receptors when cultured in low 
concentrations of LN-1 [33].  It is possible that in the 0.017 µg/ml/mm LN-1 gradient 
scaffolds, DRGs express more receptors for LN-1 (at the growth cones) than in the 0.051 
µg/ml/mm and the 0.121 µg/ml/mm gradient scaffolds. Substrate-cytoskeletal coupling in 
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the growth cone could transmit mechanical forces to pull the growth cone or its contents 
toward the anchored adhesive site. Therefore, in the anisotropic LN-1 scaffolds with 
lower slopes, higher density of receptors might lead to faster neurite growth rates by 
haptotactic mechanism.  
In summary, a novel technique to fabricate anisotropic LN-1 containing hydrogel 
scaffolds was fabricated and characterized.  The results clearly demonstrate that scaffolds 
with gradients of LN-1 can promote faster neurite growth rate than maximal growth rate 
possible in isotropic LN-1 scaffolds.  The results also demonstrate that there exists an 
optimal ‘slope’ for the gradient of LN-1, with the lowest slope in the range tested being 
the most optimal for the highest neurite growth rate.  Although some studies have been 
done to understand how neural cells regulate their integrin expression in response to 
different isotropic concentrations of LN [33], in future studies it would be interesting to 
investigate how neurites adapt to changing concentrations of LN as in the case of 
gradients.  Such anisotropic scaffolds, with directional cues, are likely to enhance 
peripheral nerve regeneration in vivo when presented across nerve gaps inside carrier 
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Chapter 3.  ANISOTROPIC AGAROSE HYDROGEL SCAFFOLDS ENHANCE 
NERVE REGENERATION ACROSS LONG NERVE GAPS IN RODENTS 
 
This chapter is in preparation as a manuscript. 
 Tubular Polysulfone guidance channels filled with anisotropic scaffolds, agarose 
hydrogels containing gradients of laminin-1 (LN-1) and nerve growth factor (NGF), were 
implanted to promote sciatic nerve regeneration across a 20-mm nerve gap in rats.  
Isotropic scaffolds with uniform concentration of LN-1 and NGF were used as negative 
control, and sciatic nerve grafts harvested from syngenic rats were used as positive 
control.  4-months after implantation, regenerating axons were found only in the scaffolds 
having gradients of both LN-1 and NGF molecules.  Anisotropic scaffolds with gradient 
of only LN-1 or only NGF, with the other component at uniform concentration, did not 
result in axonal formation as observed by histological analysis.  This suggests that LN-1 
and NGF act synergistically to enhance nerve regeneration.  Nerve grafts also resulted in 
axonal regeneration across the 20-mm nerve gap.  The total number of myelinated axons 
was similar for anisotropic scaffolds and nerve grafts, with the anisotropic scaffolds 
having higher density of axons than nerve grafts.  Axonal diameter distribution was 
similar for anisotropic scaffolds and nerve grafts.  Nerve grafts, however, resulted in 
better functional outcome as measured by relative gastrocnemius muscle weight 
(RGMW) and electrophysiology.  These results indicate that for nerve regeneration over 
long-nerve gaps, anisotropic scaffolds perform better than isotropic scaffolds.  However, 
the concentrations of LN-1 and NGF in the anisotropic scaffolds need to be optimized to 
perform better than nerve grafts.    
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3.1. Introduction 
 Severe traumatic nerve injuries, tumor removal and congenital anomalies may 
result in injuries to critical nerves, and formation of a nerve gap.  Failure to repair the 
nerve gaps can result in the loss of muscle function, impaired sensation and/or painful 
neuropathies.  In case of a small nerve gap (< 2-mm long), the injury can be repaired by 
approximating the two injured nerve ends and suturing/gluing them together [86,140].  
When the nerve gap is longer than 2-mm, as in most clinical conditions, the standard 
technique is to transplant autologous nerve graft from an uninjured site to the injured site.  
Even though nerve grafts are considered as the ‘gold standard’ for nerve repair, they do 
not result in complete nerve regeneration and recovery [114,166].  In addition, an 
autologous nerve graft also suffers from the drawbacks that it requires sacrifice of a 
healthy functional tissue, and additional surgery time.  To avoid the problems with 
autografts, allografts from cadavers have been used.  However, allografts usually require 
preservation between surgeries and systemic immunosuppression in recipients, both of 
which can reduce allograft performance [62,115].   
To overcome the limitations with natural materials, synthetic tubular nerve 
guidance channels have been used with promising results [6,10,26,151].  The 
performance of nerve guidance channels (NGCs) can be further enhanced by varying its 
properties, such as, porosity [2], electrical activity [5,153], and surface roughness [3].  In 
the presence of distal nerve stump, silicone NGCs can promote spontaneous nerve 
regeneration over 10-mm nerve gaps in rats.  However, regeneration fails if the nerve gap 
is increased to 15-mm or longer [36,103].  To enhance the performance of NGCs, 
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additional filler materials (such as hydrogels), growth factors, extracellular matrix (ECM) 
proteins, and fibers have been used [46,105,107,147].  
The ECM protein laminin (LN), found in the basement membrane of most cells, is 
a potent stimulator of neurite outgrowth in neurons from peripheral and central nervous 
systems.  Also, LN enhances attachment and migration of neuronal cells and increases 
survival of neurons [84,101,122,124].  Nerve growth factor (NGF) is a neurotrophic 
factor produced by the target organs of sympathetic and sensory nerves [12].  NGF has 
been shown to stimulate and promote neurite outgrowth and the survival of sensory 
neurons and axons, including those from spinal sensory nerves and sciatic nerves 
[73,95,145].  Due to their potent functions, LN and NGF have been used successfully for 
nerve regeneration, both in vitro and in vivo [7,13,24,38,164].   
Various hydrogel scaffolds, including agarose, have been used to promote 
neuronal growth, both in vitro and in vivo [130,141,159].  Agarose hydrogel is a 
polysaccharide derived from red algae.  In cell cultures, SeaPrep® agarose has been 
shown to support neurite extension from a variety of neurons in a non-immunogenic 
manner [15,40,89,137].  Agarose gels also allow molecules to be covalently linked to the 
gels through functional groups on its polysaccharide chains.  For example, LN-1 protein 
(isoform of LN) or fragments of LN-1 can be covalently coupled to SeaPrep® agarose 
gels to further enhance their ability to support neurite extension [164].  Photochemical 
conjugation can be used to photoimmobilize gradients of LN-1 in agarose gels to promote 
enhanced and directed neurite extension in vitro [42].   
Neurotrophic factors used to promote nerve regeneration have short half-lives, 
and hence, in case of regeneration over long nerve gaps, ideally need to be slow-released 
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using delivery vehicles.  For slow-release of neurotrophic factors, phosphatidyl choline 
based lipid microtubules have been developed [127,136].  Lipid microtubules (LMTs) are 
ideal for trophic factors because these sensitive proteins can be loaded into microtubules 
in an aqueous environment without exposure to organic solvents.  LMTs can also be 
easily incorporated in agarose scaffolds, when culturing neuronal cells, for slow-release, 
without physically impeding the growth cones that navigate the scaffolds.  By controlling 
the amount of protein loaded into the microtubules, the number of microtubules used, and 
the length of microtubules; it is possible to control the duration of release of protein and 
the amount of protein released [113]. 
  Tissue-engineered scaffolds have been successful in promoting nerve regeneration 
comparable to nerve grafts, across short nerve gaps (10-mm or less).  Polymer guidance 
channels with uniform concentrations (isotropic) of LN-1 and NGF promote nerve 
regeneration comparable to that of autografts over 10 mm nerve gaps in rodents [163].  
However, we believe that for longer nerve gaps, 15-mm or more in rodents or over 80 
mm in humans, which is clinically more relevant, isotropic scaffolds might not be able to 
match the performance of autogratfts.  Anisotropic agarose hydrogel scaffolds, with 
gradients of LN-1, have been shown to promote enhanced neurite extension from chick 
dorsal root ganglia (DRG) in vitro as compared to isotropic scaffolds [42].  DRG cultured 
in these anisotropic scaffolds extend neurites longer and faster than DRG cultured in 
isotropic LN-1 scaffolds.  Similarly, gradients of NGF can initiate turning of neurites 
towards the NGF-source [52], and guide the neurite growth [23,24].  We hypothesize that 
anisotropic scaffolds with gradients of both LN-1 and NGF will promote better nerve 
regeneration than isotropic scaffolds over large nerve gaps.  Here, we present our 
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techniques to synthesize anisotropic scaffolds using agarose gels, the animal model we 
have used, analyses for nerve regeneration and behavior studies, and the results.  
 
3.2. Materials and Methods 
3.2.1. Design of Tissue-Engineered Scaffolds 
3.2.1.1. Preparation of Polymer Guidance Channel        
Tubular Polysulfone guidance channels were used to present the LN-1 and NGF-
containing agarose hydrogel scaffolds, for sciatic nerve regeneration in rats.  Polysulfone 
guidance channels (Koch Membrane System, Ann Arbor, MI), with an inner diameter of 
1.6 mm, an outer diameter of 3.2 mm, and length of 22 mm, were used for supporting the 
agarose gel scaffolds.  Before filling the guidance channels with the agarose scaffold, 
they were sterilized by immersion in 70% ethanol solution for 2 days, dried under a clean 
laminar flow hood, and washed with sterilized Phosphate Buffered Saline (PBS) 
(Mediatech Inc., Herndon, VA).  The guidance channels were kept hydrated in 0.1M PBS 
(pH 7.4) until they were filled with agarose scaffolds.  
 
3.2.1.2. Synthesis of LN-1 coupled Agarose Hydrogels and Lipid Microtubules for Slow 
Release of NGF  
Agarose gel scaffolds were designed with three components: 0.5% (w/v) agarose 
hydrogel, LN-1, and NGF-loaded microtubules; for spatially and temporally controlled 
presentation of ECM and trophic factors in vivo.  First, thermo-reversible SeaPrep® 
agarose hydrogels (BMA, Rockland, Rockland, ME) were covalently coupled with ECM 
protein LN-1 using photochemical conjugation [42].  Briefly, LN-1 (BD Biosciences, 
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Bedford, MA) was first conjugated to a bi-functional photochemical crosslinker, Sulfo-
SANPAH (Sulfosuccinimidyl-6-[4’-azido-2’-nitrophenylamino] hexanoate) (PIERCE, 
Rockford, IL) through the amine groups on the LN-1 molecule.  Agarose solution was 
then added to this LN-1 – Sulfo-SANPAH conjugate such that final concentration of 
agarose is 1% (w/v).  The solution mixture was then exposed to ultra-violet light, binding 
LN-1 to agarose through the photocrosslinker.  The solution was then solidified into gel 
by cooling in a refrigerator for 20 minutes.  Over the next 2 days, the gel was washed 
using 0.1M PBS, with repeated changes, to remove uncoupled LN-1.  LN-1 conjugated 
agarose hydrogel was then liquefied by heating at 45oC, cooled to room temperature, 
mixed with NGF-loaded microtubules and injected into polymer guidance channels.  
Amount of LN-1 conjugated to agarose hydrogel was quantified by Bradford protein 
assay (BIO-RAD, Hercules, CA). 
A novel drug delivery system using lipid microtubules (LMTs) of 1,2-bis (tricosa-
10,12-diyomoyl)-sn-3-phosphocholine (DC8,9PC; Avanti Polar Lipids, Inc., Alabster, 
AL) was prepared by ethanol deposition method, and used for slow-release of NGF, as 
described in other studies [113,164].  The LMTs had an average length of 45±20 µm 
(Figure 3-1).  NGF was loaded into the LMTs by hydration of 10 mg of lyophilized 
LMTs with 400 µl of PBS containing 48 µg of NGF (120 µg/ml NGF solution).  The 
NGF loaded LMTs were then mixed with equal volume of 1% plain agarose or LN-1 








3.2.1.3. NGF release from NGF-loaded Microtubules  
 A study was designed to assess the long-term release of NGF from LMTs.  LMTs 
were first synthesized by ethanol deposition method [113].  A total of 10 mg of LMTs 
was rehydrated with NGF solution (0.4 ml of 120 µg/ml solution) overnight at 4oC.  The 
solution was then centrifuged to precipitate LMTs, and the supernatant containing free 
NGF was removed.  The LMTs were mixed with equal volume of 2% agarose solution 
(w/v) to form a 1% (w/v) LMTs-embedded agarose solution.  300 µl of the mixture was 
added to a 24 well-plate dish (Corning Inc., Corning, NY) and cooled in refrigerator 
(4oC) for 20 minutes, to allow it to gel.  500 µl of PBS was added on top of the gel block 
Figure 3-1: Lipid microtubules. Phase- contrast 
image of lipid microtubules from DC8,9PC lipid.  
Scale bar = 100 µm.  
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and the 24 well-plate dish was maintained at 37oC.  NGF slowly released from the two 
open ends of LMTs diffused into the PBS solution.  The solution was replaced with fresh 
PBS daily, and the amount of NGF in the supernatant was quantified using an NGF 
ELISA Kit (Chemicon International, Temecula, CA) to determine the amount and 
duration of NGF-release from the LMTs. 
 
3.2.1.4. Synthesis of Isotropic Scaffolds 
Isotropic scaffolds with uniform concentration of LN-1 and NGF were designed 
as described below.  LN-1 conjugated agarose solution (66 µg of LN-1/ml of 1% agarose) 
was synthesized as described in section 3.2.1.2., and mixed with an equal volume of 
LMTs in PBS solution (9.6 X 108 LMTs/ ml of PBS, loaded with 120 µg/ml of NGF).  
This resulted in 0.5% agarose solution with LN-1 (33 µg/ml) and NGF-loaded 
microtubules.  The agarose solution mixture was then injected into Polysulfone guidance 
channels using a 1 ml syringe fitted with 22G needles (Becton Dickinson & Co., Franklin 
Lakes, NJ) and gelled by cooling at 4oC for 10 minutes.  These scaffolds were kept 
hydrated in 0.1M PBS until implantation in rats, on the same day.   
Two kinds of anisotropic scaffolds were designed, one with step-gradients, and 
the other with continuous-gradients.  Both, step-gradient and continuous-gradient 
scaffolds had four layers of gels from one end of the tube to the other, each with higher 
concentration of NGF than the previous layer.  However, in a step-gradient scaffold the 
LN-1 concentration increased in step-wise manner from one layer to another (Figure 3-2), 
whereas, in a continuous-gradient scaffold the LN-1 concentration increased smoothly 
from one end of tube to the other end (Figure 3-3).     
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Figure 3-2: Schematic of LN-1 and NGF distribution in step-gradient anisotropic scaffolds. 
Gel 4 has higher concentration of LN-1 than gel 3 and so on (A). Similarly gel 4 has higher 
concentration of NGF than gel 3 (B) and so on.  While LN-1 gradient is immobilized, with 




























The NGF-loaded LMTs and 1% (w/v) LN-1-agarose solution (66 µg of LN-1/ml) 
were mixed at 1:1 ratio to prepare 0.5% (w/v) agarose solution with immobilized LN-1 
(33 µg/ml) and mixed in NGF-loaded LMTs (solution 4).  Solution 4 was diluted with 
0.5% agarose solution to form solution 3 with lower concentration of LN-1 and NGF-
loaded LMTs.  Similarly, solutions 2 & 1 were made.  Solution 4 was first injected into 
the polymer guidance channel to fill 25% of space and allowed to gel.  The solutions 3, 2 
and 1, were then injected into the polymer guidance channel, one after the other, to make 
four layers of gels.  The four layers resulted in increasing concentrations of LN-1 and 
NGF from one end of tube to the other end (Figure 3-2). 
 
3.2.1.6. Synthesis of Continuous-Gradient Anisotropic Scaffolds 
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To design anisotropic scaffolds with continuous-gradients of LN-1 and NGF, first 
step-gradient of NGF was synthesized and a LN-1 gradient was made later.  A 0.5% 
agarose solution mixture (solution 4) was first made by mixing 1% agarose solution (no 
LN-1) with equal volume of NGF-loaded LMTs (9.6 x 108 LMTs/ml of PBS).  Solution 4 
was diluted with 0.5% plain agarose solution to make Solution 3, with lower 
concentration of NGF-loaded LMTs.  Similarly, solution 2 & 1 were made.  Solution 4 
was first injected into the polymer guidance channel to fill 25% of space, and allowed to 
gel by cooling. The solutions 3-1 were then injected into the polymer guidance channel, 
one after the other; to make four layers of gels, with increasing concentrations of NGF-
loaded LMTs (no LN-1).  A LN-1 gradient was then made by allowing controlled 
diffusion of LN-1-sulfo-SANPAH solution into the guidance channel through one of its 
ends. The LN-1 gradient was then immobilized by UV-photocrosslinking.  Figure 3-3 
shows a schematic of distribution of LN-1 (Figure 3-3A) and NGF-loaded LMTs (Figure 
3-3B) in these scaffolds.  To make anisotropic scaffolds with gradient of LN-1 but 
uniform NGF concentration, solutions 4-1 with same concentration of NGF-loaded LMTs 
were used, and then a diffusion gradient of LN-1 was made. 
To determine the concentration profile of LN-1 in continuous-gradient scaffolds, 
the tubes were cut transversely into 4 parts, 5-mm each.  The total amount of LN-1 in 
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Figure 3-3: Schematic of LN-1 and NGF distribution in continuous-gradient anisotropic scaffolds. LN-
1 gradient is smooth (A) while NGF is distributed in a step-gradient fashion initially (B). With 




























3.2.1.7. Different Groups of nerve implants 
Nerve guidance channel (NGC) implants were separated into eight groups 
depending on their constituents, as described in Table 3-1.  Control group I (Saline) 
contained 1X PBS solution.  Control group II (Plain agarose) contained 0.5% agarose 
solution without any LN-1.  Control group II (LN(U)) contained channels filled with LN-
1-coupled 0.5% agarose gel (33 µg/ml of LN-1).  Control group IV (nerve graft) 
consisted of 20-mm long nerve grafts harvested from isogenic Fisher inbred rats.  
Experimental group I (LN(U)-NGF(U)) consisted of implants with uniform concentration 
of LN-1 and NGF.  Experimental group II (LN(U)-NGF(SG)) consisted of implants with 
uniform concentration of LN-1 and step-gradient of NGF.  Experimental group III 
(LN(SG)-NGF(U))  consisted of implants with step-gradient of LN-1 and uniform 
concentration of NGF.  Experimental group IV (LN(SG)-NGF(SG))  consisted of step- 
gradients of both LN-1 and NGF. 
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(U) = uniform concentration, (SG) = step-gradient, (CG) = continuous-gradient 
 
 
Experimental group V (LN(CG)-NGF(U)) consisted of continuous gradient of LN-1 and 
uniform concentration of NGF.  Experimental group VI (LN(CG)-NGF(SG)) consisted of 
implants with continuous gradient of LN-1 and step-gradient of NGF.  After preparation, 
Table 3-1: Description of experimental and control groups for in vivo study 




(negative) Saline PBS solution 5 
Control II 




Isotropic LN-1-agarose gels  5 
Control IV 
(positive) Nerve graft 
 
Nerve grafts explanted from other 
Fischer inbred rats 
8 
Experimental I LN(U)-NGF(U) 
 
Isotropic LN-1-agarose gels embedded 
with isotropic NGF-loaded LMTs 
10 
Experimental II LN(U)-NGF(SG) 
 
Isotropic LN-1-agarose gels embedded 
with anisotropic NGF-loaded LMTs 
9 
Experimental III LN(SG)-NGF(U) 
 
Anisotropic LN-1-agarose gels 
embedded with isotropic NGF-loaded 
LMTs 
11 
Experimental IV LN(SG)-NGF(SG) 
 
Anisotropic LN-1-agarose gels 
embedded with anisotropic NGF-loaded 
LMTs 
9 
Experimental V LN(CG)-NGF(U) 
Anisotropic LN-1-agarose gels 
embedded with isotropic NGF-loaded 
LMTs 
7 
Experimental VI LN(CG)-NGF(SG) 
 
Anisotropic LN-1-agarose gels 




these implants were stored at 4oC in 0.1M PBS until implantation in vivo, usually within 
2-3 hours.   
 
3.2.2. Implantation of Tissue Engineered Scaffolds 
We have used rat sciatic nerve injury model to test for nerve regeneration.  Adult 
Fischer inbred male rats (Harlan) weighing between 300-350g were used.  The rats were 
anesthetized using inhaled isofluorane gas (3-4% v/v for induction, 1.5-2% for 
maintenance, Airco, Inc., Madison, Wis.).  The right thigh region was shaved and the 
skin was sterilized by applying chlorohexidine solution (2%, First Priority, Inc., Elgin, 
IL) and 70% ethanol alternatively, 2-3 times.  A 25-mm long skin incision was made 
along the femoral axis.  The thigh muscles were separated and the sciatic nerve was 
dissected free.  Using micro-scissors, the nerve was transected and a 5-mm nerve 
segment was explanted.  The proximal and distal nerve stumps were secured 20-mm apart 
in a 22-mm long polymer guidance channel carrying experimental or control gel 
formulations, using a 10-0 Nylon monofilament suture (Ethicon Inc., Somerville, NJ).  In 
case of positive control group, the nerve gap was bridged using a 20-mm long syngenic 
nerve graft obtained from another Fischer inbred rat.  The muscles were then closed using 
a 4-0 vicryl suture (Ethicon Inc., Somerville, NJ) and the skin was closed using wound 
clips (Braintree Scientific, Inc., Braintree, MA).  0.2 ml of Marcaine (0.25% w/v, Hospira, 
Inc., Lake Forest, IL) per rat was administered subcutaneously for pain relief.  NIH 
guidelines for using experimental animals were followed both pre- and post-surgery.  The 
explanted 5-mm nerve was fixed in para-formaldehyde and prepared for histological 
analysis to evaluate the native nerve prior to injury.    
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In case of anisotropic scaffolds the tubes were sutured to the nerve such that the 
concentration of LN-1 and NGF-releasing LMTs increases from the proximal end to the 
distal end.  The rats were under observation for 16 weeks.  
 
3.2.3. Evaluation of Nerve Regeneration 
3.2.3.1. Histological Analysis for Nerve Regeneration 
16 weeks post-implantation, after electrophysiological examinations, the rats were 
administered, intraperitoneally, an overdose of rodent anesthetic cocktail (consisting of 
ketamine at 65mg/kg of rat weight, xylazine at 7.5mg/kg, and acepromazine 0.5mg/kg).  
The rats were then perfused intracardially with saline, followed by cold 4% 
parafomaldehyde and 0.25% gluteraldehyde (both from Sigma-Aldrich, St. Louis, MO) in 
PBS.  The site of nerve injury was opened and the implant (polymer guidance channel or 
nerve graft) was removed for histological analysis.  Along with the nerve implant, the 
gastocnemius muscle from the right (experimental side) and left (control side) limb were 
also explanted.  All the harvested tissues were post-fixed in 4% parafomaldehyde, 
overnight.   
The nerve explants were cut into three parts: proximal, middle and distal, and 
additionally post-fixed, overnight, with 1% osmium tetroxide in PBS.  After washing 
with PBS and dehydration in graded ethanol series, the three parts were separately 
embedded in LX112 resin (Ladd Research Industries, Inc., Burlington, VT).  Semi-thin 
sections (0.5 µm) of nerve explants were cut using microtome, stained with Toluidine 
blue (0.1%, Sigma, St. Louis, MO) and observed under a light microscope.  Ultra-thin 
sections (100 nm) were observed under electron microscope.   
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Nerve regeneration was evaluated by: a) percentage of guidance channels with 
successful nerve regeneration, indicated by presence of myelinated axons, b) the total 
number of myelinated axons in the middle (at 10-mm) and the distal end (at 17-mm) of 
the guidance channels/autografts, c) the area of axonal regeneration, d) the number of 
myelinated axons per unit area (density) at the middle and distal points of the guidance 
channel/autografts; and e) the diameter distribution of regenerated axons for each group.  
For quantification, images were captured using Sony digital photo camera (Japan) 
attached to Nikon Eclipse TE 300 microscope (Japan) running ImagePro software (Media 
Cybernetics, L.P., Silver Spring, MD).  First, images were captured using 4x or 10x 
objective lenses to determine the area of axonal regeneration, and then images were 
captured using 100x objective lens to count the number of myelinated axons.  4-5 images 
(at 100x) were captured for each nerve implant, so that 15-50% of area of regeneration 
was used for analysis.  One-way ANOVA was used for statistical comparison of the 
various groups.   
 
3.2.3.2. Relative Gastrocnemius Muscle Weight Measurement 
The gastrocnemius muscle is innervated by the sciatic nerve, and starts atrophying 
after nerve transection injury.  The gastrocnemius muscle from the right and left limb 
were harvested after the rat had been sacrificed.  The weight of the muscle was measured 
and used to calculate relative gastrocnemius muscle weight (RGMW).  The RGMW, 
which is defined as the ratio of muscle from the experimental side to the control side, was 
used as one of the parameter for motor function recovery.  The RGMW should increase 
with the sciatic nerve regeneration.  
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3.2.3.3. Neuromuscular junction (end plates), synaptic vesicles and neurofilament 
staining 
Gastrocnemius muscle explanted from the experimental rats were post-fixed 
overnight in 4% paraformaldehyde, washed with saline solution and left overnight in 
30% sucrose solution.  The muscle tissue was then cryoembedded.  Longitudinal sections, 
25 µm thick, were cut using a Microtome (Cryo-star HM 560MV, Microm, Waldorf, 
Germany).  Tissue sections were collected every 800 µm, and processed for the following 
markers: neurofilament 160 (NF160, Sigma-Aldrich, St. Louis, MO), synaptic vesicles 2 
protein (SV2, Developmental Studies Hybridoma Bank, Iowa City, IA), and 
acetylcholine receptors (using alpha-Bungarotoxin-tetramethlyrhodamine, Sigma-Aldrich, 
St. Louis, MO). 
   
3.2.3.4. Electrophysiological Recordings to Test for Nerve Reconnection 
To test for regeneration of axons through the implant and functionality of the 
regenerated nerve, compound action potentials (CAPs) across the implant were measured.  
Sixteen weeks post-implantation, prior to perfusing the rat for implant retrieval, 
electrophysiological recordings were done under anesthesia.  The experimental rats were 
anesthetized using 0.7ml of rodent cocktail/kg of rat weight (consisting of ketamine at 
65mg/kg of rat weight, xylazine at 7.5mg/kg, and acepromazine 0.5mg/kg), administered 
intraperotineally.  The sciatic nerve, posterior tibial nerve and triceps surae muscles were 
exposed on the right limb.  The sciatic nerve was stimulated 5-mm proximal to the 
implant and whole nerve CAPs were recorded 40-mm distal to the implant.  The nerve 
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was stimulated using a platform electrode (1 Hz, 3 ms, variable amplitude).  Recordings 
were amplified 10,000 times, filtered at 10 Hz (low pass) and 3 kHz (high pass), acquired 
using LabVIEW software, and stored for offline averaging and analysis using MATLAB 
software.  CAPs were also measured from the control side (left sciatic nerve) for 4 rats 
and denoted as “normal” CAPs.  
 
3.2.3.5. Walking Track Analysis for Evaluation of Functional Recovery  
Free, spontaneous locomotion in animals is highly consistent and readily 
quantifiable.  In 1982, De Medinaceli et al. [37] designed a quantitative method of 
analyzing the sciatic nerve function in rats, known as the sciatic function index (SFI). 
A walking track was designed to visualize and record gait of rats in an enclosed 
walkway (Figure 3-4).  Each experimental rat was allowed to walk freely in the walkway 
and its movements were recorded using a digital camera.  The video sequences of rat gait 
were edited in QuickTime Player (Apple Computer, Inc.) to capture the foot prints.  The 
foot prints were then analyzed to measure (i) distance from the heel to the third toe, 
called as the print length (PL); (ii) distance from the first to the fifth toe, the toe spread 
(TS); and (iii) distance from the second to the fourth toe, the intermediate toe spread 
(ITS).  All these measurements were taken from the experimental (E) and normal (N) 
sides.  These measurements were used to calculate the factors as follows: (i) print length 
factor (PLF) = (EPL-NPL)/NPL; (ii) toe spread factor (TSF) = (ETS-NTS)/NTS; (iii) 
intermediate toe spread factor (ITF) = (EIT-NIT)/NIT.  These factors were then 






SFI = -38.3 x PLF + 109.5 x TSF + 13.3 x ITF -8.8   
A SFI value of 0 is considered normal.  A SFI of -100 indicates total impairment, 
as it would be for a complete transection of the sciatic nerve.  If there is functional 
recovery due to regeneration techniques, the SFI should increase from -100 towards 0.  















Figure 3-4: Schematic showing the measurement of rodent sciatic function. A. Schematic 
of imaging setup. B. An example of a captured footprint during gait. C. The three 
variables measured from the footprint. ITS= Intermediate Toe Spread, TS= Toe Spread, 
and PL= Print Length. 
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3.2.3.6. Statistical analysis  
The data were expressed as mean ± SEM.  A one-way ANOVA was used to 
compare the data between groups for histological analysis and functional analysis.  A p-
value < 0.05 was considered statistically significant. 
 
3.3. Results  
3.3.1. LN-1 and NGF distribution in Isotropic and Anisotropic Scaffolds 
LN-1 Concentration in Isotropic Scaffolds 
Bradford assay (BIO-RAD, Hercules, CA) was used to determine the amount of 
LN-1 coupled to agarose gel.  Efficiency of the conjugation technique was about 10-15%.  
LN-1-agarose gel with LN-1 concentration of 66 µg/ml of 1% agarose solution was used 
for in vivo experiments. 
 
NGF Release Study 
In vitro NGF-release from LMTs was followed up to 18 days.  The amount of 
NGF released into the supernatant (PBS solution) was determined by NGF ELISA kit 
(Figure 3-5).  For the first 6 days, the cumulative amount of NGF released was linear and 
rapid, and for the next 12 days the cumulative release still increased linearly, but less 
rapidly.  The amount of NGF released at 18th day was still much above the detection limit 
for the ELISA kit, indicating that NGF could be released for more than 18 days from the 
LMTs.      
 
LN-1 distribution in anisotropic scaffolds 
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LN-1 distribution in continuous-gradient anisotropic scaffolds was determined by 
LN-1 ELISA.  The 20-mm scaffolds were cut transversely into 4 parts, 5-mm each, and 
LN-1 ELISA was performed.  In Figure 3-6, LN-1 concentration distribution is plotted 
along the length of NGC.  The average LN-1 concentration in a 5-mm section has been 
plotted at mid-length (i.e. 2.5-mm, 7.5-mm, etc.).  LN-1 distribution closely followed a 
second-order polynomial.  The continuous-gradient anisotropic scaffolds with LN-1 
distribution close to that of isotropic scaffolds (4 layers of gel with 33 µg/ml, 25 µg/ml, 











0 2 4 6 8 10 12 14 16 18 20
Days
Figure 3-5: NGF-release study, in vitro.  NGF-release from LMTs was 
followed up to 18 days.  For the first 6 days, cumulative amount of NGF-
released was linear and rapid.  For the next 12 days, the release was less 
















































































Figure 3-6: LN-1 concentration distribution in continuous-gradient anisotropic 
scaffolds. 20-mm long nerve guidance channels with continuous-gradients of LN-1 
were cut into 4 parts, each 5-mm long, and their LN-1 content was determined. 

















3.3.2: Histological Analysis for Nerve Regeneration 
3.3.2.1. Presence of Regenerating Axons in Nerve Implants  
Presence of myelinated axons was indentified by OsO4 and toulidine blue staining.  
Nerve implants with positive staining for myelinated axons were counted as successful in 
promoting axonal regeneration.  A total of 10 groups were studied and only 3 groups had 
axonal regeneration through the implants, as determined by histological analysis (Table 
3-2, below).  The 3 groups were, rats with nerve grafts, LN(SG)+NGF(SG) (step-gradient 
of LN-1 and NGF), and LN(CG)+NGF(SG) (continuous-gradient of LN-1 and step-
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gradient of NGF).  The success rate was highest for nerve grafts (83.3%), followed by 
LN(SG)+NGF(SG) (44.4%) and LN(CG)+NGF(SG) (37.5%) (Table 3-2).  Rest of the 
histological analysis (axonal area, number of myelinated axons, etc.) could be done for 




Table 3-2: Summary of Nerve Regeneration in Control and Experimental Groups 
Groups Total # of rat # of rats with axon 
regeneration 
% regeneration 
Saline 5 0 0 
Plain agarose 5 0 0 
LN(U) 5 0 0 
LN(U)+NGF(U) 10 0 0 
LN(U)+NGF(SG) 9 0 0 
LN(SG)+NGF(U) 11 0 0 
LN(SG)+NGF(SG) 9 4 44.4 
LN(CG)+NGF(U) 7 0 0 
LN(CG)+NGF(SG) 8 3 37.5 
Nerve graft 6 5 83.3 
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Figure 3-7: Light micrographs of nerve sections of groups with successful regeneration. Toluidine-blue 
stained cross-sections at mid-length (10-mm) of nerve implants are shown here. Anisotropic scaffolds 
with step-gradient (A) and continuous-gradient (B) of LN-1, have higher density of axons and smaller-













The photographs of histology specimen of cross sections at the mid-point of nerve 
guidance channels/autografts/normal nerve are shown in Figure 3-7 (A-D).  The gross 
structure of the regenerated nerves was similar to the normal sciatic nerve.  Regenerated 
axons were packed in bundles to form fascicles, and several fascicles were enclosed in 
the connective tissues of epineurium.  Large numbers of nuclei from Schwann cells 
clearly surrounded the regenerated axons.  There were abundant blood vessels in the 
epineurium of regenerated nerves.  The implanted agarose gels were completely resorbed 
without any trace.  
 
3.3.2.2. Axonal Area of Regeneration: 
The area occupied by regenerating axons was outlined and measured using 
ImagePro® software.  The area of regeneration was determined at mid-length (10-mm) 
and distal end (17-mm) of the implants for the 3 groups which showed presence of 
myelinated axons.  The area was significantly higher for the nerve grafts than the 
anisotropic scaffolds.  However, there was no significant difference between the two 
anisotropic scaffolds, LN(SG)+NGF(SG) and LN(CG)+NGF(SG) group (Figure 3-8).  
For all the 3 groups, there was no significant difference between the area of regeneration 
at mid-length (10-mm) and at distal end (17-mm).   
 
3.3.2.3. Total Number of Myelinated Axons and the Density of Myelinated Axons 
For all 3 groups, there was no significant difference between the total number of 
myelinated axons at mid-length (10-mm) and at distal end (17-mm) (Figure 3-9).  At 
mid-length, the total number of myelinated axons in the nerve grafts and the 
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LN(SG)+NGF(SG) (step-gradient) implants were not significantly different.  However, at 
mid-length, the number of myelinated axons in the LN(CG)+NGF(SG) (continuous-
gradient) implants was less than that of nerve grafts.  At distal end (17-mm), there was no 
significant difference between the 3 groups.  The number of myelinated axons in a 
normal sciatic nerve has also been shown here.  The total number of myelinated axons in 
the nerve grafts and the LN(SG)+NGF(SG) group is comparable to a normal sciatic nerve 
(Figure 3-9).  However, the LN(CG)+NGF(SG) group has lower number of myelinated 




Figure 3-8: Area of nerve regeneration.  For all three groups, 
there was no significant difference between area of 
regeneration at distal end and at the middle.  At midpoint, 
nerve graft has higher area of regeneration than either 
anisotropic scaffold group (# p-value < 0.05). However, at 
distal end, area in nerve graft is higher compared to 































3.3.2.2. Total Number of Myelinated Axons and the Density of Myelinated Axons 
For all 3 groups, there was no significant difference between the total number of 
myelinated axons at mid-length (10-mm) and at distal end (17-mm) (Figure 3-9).  At 
mid-length, the total number of myelinated axons in the nerve grafts and the 
LN(SG)+NGF(SG) (step-gradient) implants were not significantly different.  However, at 
mid-length, the number of myelinated axons in the LN(CG)+NGF(SG) (continuous-
gradient) implants was less than that of nerve grafts.  At distal end (17-mm), there was no 
significant difference between the 3 groups.  The number of myelinated axons in a  
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The regenerated nerve cables were more densely packed in the anisotropic 
scaffolds than the nerve grafts and a normal nerve (Figure 3-10).  The fiber density in 
anisotropic scaffolds is almost twice that of nerve grafts and five times that of a normal 
nerve.  
 
3.3.2.4. Nerve Fiber Diameter Distribution 
Nerve fiber diameter was measured using ImagePro® software to determine the 
diameter distribution of regenerated nerve fibers, at mid-length and distal end.  The 
diameter distribution followed a bell-shaped curve (Figure 3-11a).  The peak of the curve, 
i.e., the maximum number of nerve fibers, was in the 1-2 µm diameter range for the nerve 
grafts as well as the anisotropic scaffolds.  However, the fiber-diameter distribution in a 
normal nerve was a bell-shaped curve with a much wider spread.  In a normal nerve the 
maximum number of fibers had a diameter range from 2-5 µm.  The fiber diameter 
distribution pattern at distal end (17-mm) was similar to that at mid-length (10-mm) 
(Figure 3-11b).  Hence, the nerve implants have more regenerated nerve fibers in the 
smaller diameter range than a normal nerve, but fewer nerve fibers in the larger diameter 























Figure 3-11a: Diameter distribution of nerve axons at mid-length (10-
mm).  For each group the diameter distribution is a bell-shaped curve.  
For all the nerve implants, the maximum number of axons have diameter 
of 1-2 µm.  However, in a normal nerve the maximum diameter 
d i s t r i b u t i o n  i s  m o r e  w i d e ,  f r o m  1 - 5  µ m . 
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Figure 3-11b: Diameter distribution of nerve axons at distal end (17-mm).  For 
each group the diameter distribution is a bell-shaped curve.  For all the nerve 
implants, the maximum number of axons have diameter of 1-2 µm.  However, in 




























3.3.3. Relative Gastrocnemius Muscle Weight 
The gastrocnemius muscle starts to atrophy after sciatic nerve injury, and hence, 
its mass is directly proportional to the extent of sciatic nerve re-innervation.  There was 
no significant difference in RGMW values between LN(SG)+NGF(SG) (step-gradients) 
group and nerve grafts (Figure 3-12).  Rest of the groups had significantly lower RGMW 
values.  Although, LN(CG)+NGF(SG) (continuous-gradient) group showed RGMW 












































































Figure 3-12: Relative gastrocnemius muscle weight.  Implants with step-gradients 
and nerve grafts had comparable RGMW (p-value > 0.05).  The rest of the implant 











   
 
 
3.3.4. Neuromuscular junction, synaptic vesicles and neurofilament staining 
  25 µm thick sections of gastrocnemius muscle from normal (uninjured) rats, and 
treatment groups (nerve graft and anisotropic scaffolds) were stained for acetylcholine 
receptors (neuromuscular junctions, NMJ), neurofilament and synaptic vesiscles.  NMJ 
(red, Figure 3-13(A)) which were positive for neurofilament staining (green, Figure 3-
13(B)) and/or synaptic vesicles (green, Figure 3-13(C)) were counted and compared for 
the various groups.  In a normal rat, 38.5% of NMJs were positive for neurofilament 
and/or synaptic vesiscles.  However, in the treated groups, there were no NMJs positive 
for neurofilament and/or synaptic vesicle staining, indicating that the regenerated axons 





























































Figure 3-13: Staining for acetylcholine receptors, synaptic vesicles and neurofilaments.  
In a normal uninjured rat, nicotinic acetylcholine receptors (red, A), neurofilaments (green, 
B) and synaptic vesicles (c) could be identified.  In normal rat, 38.5% of end-plates were 
positive for NF160 and/or SV2 staining (D).  However, treated rats, nerve grafts and 








































3.3.5. Electrophysiological recordings 
4-months post-implantation, to evaluate the regeneration and maturation of the 
nerve in the grafts, CAPs were recorded between the proximal and distal ends of the 
grafts.  The distance between the stimulating and recording electrode was 60-70 mm.  
Action potentials were also recorded from normal sciatic nerves.  Action potentials could 
be recorded in nerve grafts and normal nerves (Figure 3-14).  However, action potentials 
could not be recorded from anisotropic scaffolds, even after raising the stimulating 
voltage 20-times compared to the normal nerves. Similarly, action potential could not be 
evoked in other experimental and control groups. 
 
3.3.6. Walking Track Analysis for SFI measurement 
SFI is an indication of recovery of motor function of the hind limbs.  SFI value of 
-100 indicates total impairment and value of 0 indicates normal condition.  The SFI 
values of all the eight groups were close to -100, indicating that the nerve regeneration 
observed in histological analysis did not result in significant improvement in motor 














During embryonic development of nervous system, the developing axons use a 
variety of haptotactic and chemotactic cues to find their target organs [135].  Some of 
these cues are presented in a gradient fashion in order to direct the growing axons 
towards their target tissues [16,17].  ECM proteins, such as laminin and fibronectin, and 
neurotrophic factors, such as NGF and BDNF, have been used in several studies to 
promote nerve regeneration in vivo [4,7,26].  However, these neuro-stimulatory 
molecules have not been presented in a gradient fashion as observed in vivo.  To simulate 
in vivo conditions for axonal guidance and regeneration, we present a novel technique to 
synthesize gradients of ECM proteins and neurotrophic factors for nerve regeneration in 




































































Figure 3-15: Sciatic functional index. The values of SFI for almost all groups were 
close to -100. There was no significant difference between experimental and 
control groups. “Normal” indicates an uninjured rat. 
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NGF promote enhanced axonal regeneration, as compared to isotropic scaffolds with 
uniform concentrations of LN-1 and NGF, across a challenging 20-mm nerve gap in rats.  
In the nerve injury model studied here, regeneration is limited and does not occur unless 
the nerve guidance channels have gradients of LN-1 and NGF (step- or continuous-).  
Moreover, gradients of both LN-1 and NGF are needed to promote neurite extension.  
Anisotropic scaffolds with gradient of only LN-1 or only NGF, with the other component 
at uniform concentration, did not promote axonal regeneration across the challenging 20-
mm nerve gap.  The enhanced axonal regeneration with anisotropic scaffolds, however, 
did not result in enhanced motor function recovery as measured by walking-track analysis, 
relative gastrocnemius muscle weight and electrophysiology.  
  LN-1 is an appropriate candidate as the protein of choice for PNS 
regeneration since it has been shown to be a potent stimulator of neuronal cell migration 
and neurite outgrowth [13,124,126].  In most neuronal tissues, development of the axons 
and formation of new synapses is preceded by migration of the neuronal cell bodies to the 
appropriate regions of the brain.  It has been proposed that LN facilitates these processes 
in several neural systems [19,98,167].  The spatio-temporally controlled expression of 
LN-1 in the developing peripheral nervous system, as well as the visual pathway and the 
cerebellum, suggests that LN plays a role in axon outgrowth and guidance [99,111,125].  
LN expression has been found to be essential for ventral turning of axons during 
development.  Blocking nidogen-binding motifs on LN prevents turning of axons 
although it does not affect growth [17], indicating that LN might play a role in orientation 
of axons in some systems.  NGF has been shown to stimulate and promote the survival of 
sensory ganglia and nerves, including spinal sensory nerves and sciatic nerves [95,145].  
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Griffin et al. [59] have shown concentration-dependent neurite extension/retraction with 
NGF levels.  NGF has been shown to prevent the death of axotomized sensory neurons 
completely following exogenous administration [123].  There is enough evidence to show 
that gradients of neurotrophins help in guiding developing as well as regenerating axons 
in a wide variety of neuronal systems [63,64].  Although many in vitro studies have 
shown influence of gradients of LN-1 and NGF for neurite extension, to our knowledge, 
there are no in vivo studies with gradients, due to the difficulties in making and sustaining 
gradients in vivo. 
In our study, we present a diffusion technique to first make gradients of LN-1 in 
agarose gel and then immobilize it using photochemical cross-linking.  Immobilization of 
LN-1 imitates in vivo conditions where LN-1 is tethered to the ECM.  Gradients of NGF 
were designed using slow-release LMTs, which imitate in vivo conditions.  Two kinds of 
LN-1 gradients were designed, a step-gradient and the other a continuous-gradient, to 
promote nerve regeneration.  However, the NGF gradient was always a continuous-
gradient due to the diffusion of NGF.  The step- and continuous-gradient scaffolds of LN-
1 were designed such that the average LN-1 concentration in both conditions is very close. 
However, the actual concentration of LN-1 that the regenerating axons will sense 
dynamically in each condition will be different because of the difference in gradient 
profile.  For example, over a 0-5 mm distance in step-gradients, axons will encounter a 
uniform concentration of LN-1 (8.25 µg/ml), whereas in a continuous-gradient, an 
increasing concentration profile of LN-1 will be encountered, but with an average LN-1 
concentration of 5.1 µg/ml.  The LN-1 concentration range selected for making LN-1 
step-gradients was based on the maximum concentration of LN-1 that could be 
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immobilized.  However, this concentration range may not be the optimal range.  A more 
thorough study will be needed to determine the optimal LN-1 concentration range for 
nerve regeneration. 
 Nerve regeneration over a 20-mm nerve gap in rats is challenging, and could be 
the reason for the drastic results observed in nerve histology.  Nerve regeneration was 
observed only when the scaffolds had gradients of both LN-1 and NGF.  Scaffolds with 
gradient of only LN-1 or only NGF, with the other component at uniform concentration, 
were not able to promote nerve regeneration.  This suggests a synergistic effect between 
LN-1 and NGF, as suggested in a previous study [163].     
In relative gastrocnemius muscle weight study, the anisotropic scaffolds with 
step-gradients of LN-1 were able to match the autografts for RGMW.  Rest of the groups 
had significantly lower RGMW.  This again suggests that gradients of both LN-1 and 
NGF are needed to promote nerve regeneration across a challenging nerve gap of 20-mm.  
Lower RGMW results with the continuous-gradient scaffolds, as compared to the step-
gradient scaffolds, could be due to non-optimal concentration range of LN-1 in the 
continuous-gradient scaffolds.  Even though both groups, nerve grafts and step-gradient 
scaffolds, show significant improvement in RGMW, they were still lower than the native, 
well-innervated muscle.  It is possible that the regenerating axons take longer than 4-
months to traverse the 20-mm nerve gap and the distal nerve stump, to form new 
neuromuscular junctions and cause muscle regeneration.  A study with longer duration of 
regeneration may produce higher values of RGMW for both groups.      
To determine formation of new neuromuscular junctions (NMJs), gastrocnemius 
muscle sections were stained for acetylcholine receptors positive for neurofilament and/or 
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synaptic vesicles.  Although the nerve grafts and anisotropic scaffolds were positive for 
some neurofilament and acetylcholine receptor staining, the regenerating axons did not 
connect to the acetylcholine receptors.  This indicates that the regenerating axons had not 
traveled far enough to form new NMJs.  A longer observation period (more than 4-
months) might have lead to formation of new NMJs.  
Electrophysiology studies were done to determine the maturity and extent of 
nerve regeneration through the nerve grafts.  Normal sciatic nerve (uninjured) requires 
only 0.02V stimulation to evoke action potential.  However, the nerve grafts requires 
0.22V stimulation to evoke action potential.  This could be explained based on the fiber 
diameter distribution observed in histological analysis.  For nerve grafts and anisotropic 
scaffolds, the maximum number of regenerating axons were in the 1-2 µm range, whereas, 
for a normal nerve the range was 1-5 µm.  Since the normal nerves have more nerve 
fibers with larger diameters, they are easy to stimulate than nerve grafts.  Although 
regenerating nerve fibers were observed by histological analysis in anisotropic scaffolds, 
action potentials could not be evoked.  This suggests two possibilities: either the 
regenerating nerve fibers are very small and hence could not be stimulated, or the 
regenerating nerve fibers did not reach the site of recording electrode.  The recording 
electrode was 60-70 mm distal to the stimulating electrode, and hence 40-50 mm from 
the distal end of nerve graft (since grafts are 20 mm long).  It is possible that in case of 
anisotropic scaffolds, the regenerating axons were not able to traverse the 40-50 mm 
length up to the recording electrode yet, and hence no action potentials were recorded.  
This suggests that the rate of nerve regeneration is slower in anisotropic scaffolds as 
compared to nerve grafts.  However, since we did not do histology of the nerve at the 
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recording site, it is not possible to say if the regenerating axons failed to reach the 
recording site.      
SFI data shows that there is no significance difference between the various groups, 
with all the groups having SFI values close to -100, suggesting that there was no motor 
functional recovery as measured by SFI.  It is possible that 4-months are not enough for 
sufficient number of the regenerating axons to innervate the gastrocnemius muscle and 
improve motor function.  A study with longer observation period might have resulted in 
better functional recovery.  Also, more sensitive quantitative methods including sciatic 
functional index, gait-stance duration, ankle-kinematics and toe out angle (TAO) could 
be used.  A combination of tests, each examining particular components of recovered 
sensorimotor function may lead to better overall assessment of rat sciatic nerve 
regeneration [154]. 
In summary, here we present a novel technique to synthesize anisotropic scaffolds 
with gradients of ECM proteins and neurotrophic factors for in vivo nerve regeneration.  
These scaffolds closely mimic in vivo conditions for presenting these molecules.  The 
results also demonstrate that nerve regeneration across a challenging 20-mm nerve gap is 
possible only when gradients of both LN-1 and NGF are present.  Although, the 
anisotropic scaffolds showed nerve regeneration comparable to nerve grafts, the nerve 
grafts resulted in better functional outcome as measured by RGMW and 
electrophysiology.  Optimizing the concentration of LN-1 and NGF might further 
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Chapter 4: CONCLUSIONS AND PERSPECTIVES 
 
4.1. Conclusions 
 The goals of this thesis were: 1) to develop novel three-dimensional (3D) 
anisotropic scaffolds to promote enhanced neurite extension in vitro; and 2) to develop 
3D anisotropic scaffolds with gradients of laminin-1 (LN-1) and nerve growth factor 
(NGF) to bridge long nerve gap in rats.  There are 3 main achievements: 1) 3D agarose 
hydrogel scaffolds with immobilized gradients of ECM protein, LN-1, and diffuse 
gradient of neurotrophic factor, NGF, were synthesized using diffusion technique and 
photochemical immobilization.  2) We have demonstrated that anisotropic scaffolds with 
gradients of LN-1 promote enhanced neurite extension from chick dorsal root ganglia 
(DRG), as compared to isotropic scaffolds.  3) 3D tissue-engineered agarose scaffolds 
with gradients of both ECM protein (LN-1) and neurotrophic factor (NGF) successfully 
promote nerve regeneration to bridge a challenging 20-mm nerve gap in rats; where as 
isotropic scaffolds were unsuccessful in doing so.  This model can be used to design 3D 
scaffolds with gradients for more than one molecule for in vitro and in vivo studies to 
bridge long nerve defects. 
 
4.1.1. Anisotropic Scaffolds Promote Enhanced Neurite Extension In Vitro 
 3D Agarose hydrogel scaffolds with gradients of LN-1 were synthesized 
to promote enhanced neurite extension from chick DRG.  A technique to generate diffuse 
gradients of NGF in 3D scaffolds has been previously described by Cao et al.[1].  
However, to promote regeneration across long nerve gaps, immobilized gradients may be 
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more sustainable than diffuse gradients over the period of several weeks during which 
peripheral nervous system (PNS) regeneration occurs.  This study presents a technique to 
fabricate anisotropic 3D scaffolds with immobilized gradients of LN-1 and quantitatively 
evaluates the influence of these scaffolds on chick DRG neurite extension.  Isotropic LN-
1 scaffold and plain agarose scaffold (no LN-1) were used as controls.  The results 
demonstrate that a particular concentration gradient (0.017 µg/ml/mm) of LN-1 promotes 
faster neurite extension than the highest neurite growth rate observed with isotropic LN-1 
concentration (0.5 µg/ml).  This suggests that gradients of LN-1 may be a more important 
parameter to optimize for maximal neurite extension rather than the absolute 
concentrations of isotropically distributed LN-1.  When DRGs were cultured in 
anisotropic LN-1 scaffolds with a steep slope of LN-1 gradient (0.121 µg/ml/mm or 
241% concentration difference across 2.5 mm scaffold), there was no difference in 
neurite growth rate “up the gradient”, “down the gradient” and “perpendicular to 
gradient”.  When the steepness of the gradient was reduced to 0.051 µg/ml/mm (103.3% 
concentration difference across 2.5 mm scaffold), there was difference between neurite 
growth rate “up the gradient” and “down the gradient” (p-value < 0.05).  When the 
steepness of the gradient was further reduced to 0.017 µg/ml/mm (or 35% concentration 
difference across 2.5 mm scaffold), there was even more difference between neurite 
growth “up the gradient” and “down the gradient” (p-value < 0.01).  In the anisotropic 
scaffolds used in our studies, the extending neurites were exposed to either increasing or 
decreasing gradient of LN-1.  The neurites that were exposed to decreasing gradient did 
not try to reorient themselves “up the gradient”, but continued to grow “down the 
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gradient”.  Similarly, neurites exposed to increasing gradient of LN-1 did not try to 
reorient themselves “down the gradient”.   
In summary, a novel technique to fabricate and characterize anisotropic LN-1 
containing hydrogel scaffolds was established.  The results clearly demonstrate that 
scaffolds with gradients of LN-1 promote faster neurite growth rate than maximal growth 
rate possible in isotropic LN-1 scaffolds.  The results also demonstrate that there exists an 
optimal ‘slope’ for the gradient of LN-1, with the lowest slope in the range tested being 
the most optimal for the highest neurite growth rate.  Although some studies have been 
done to understand how neural cells regulate their integrin expression in response to 
different isotropic concentrations of LN [2], in future studies it would be interesting to 
investigate how neurites adapt to changing concentrations of LN as in the case of 
gradients.  Such anisotropic scaffolds, with directional cues, are likely to enhance 
peripheral nerve regeneration in vivo when presented across nerve gaps inside carrier 
polymer nerve guidance channels. 
 
4.1.2. Bioengineered Scaffolds Promote Enhanced Nerve Regeneration in Rodents 
 To simulate in vivo conditions for axonal guidance and regeneration, a 
novel technique was designed to synthesize gradients of ECM proteins and neurotrophic 
factors.  Here we show that anisotropic agarose gel scaffolds with gradients of LN-1 and 
NGF promote enhanced axonal regeneration, as compared to isotropic scaffolds with 
uniform concentrations of LN-1 and NGF, across a challenging 20-mm nerve gap in rats.  
In the nerve injury model studied here, regeneration is limited and does not occur unless 
the nerve guidance channels have gradients of both LN-1 and NGF (step- or continuous-).  
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Axonal regeneration was evaluated by histological analysis.  Anisotropic scaffolds with a 
gradient of either LN-1 or NGF, maintaining a uniform concentration for the other 
component, did not promote axonal regeneration across the challenging 20-mm nerve gap.  
Although there was enhanced axonal regeneration in the anisotropic scaffolds, it did not 
result in enhanced motor function recovery as measured by walking-track analysis, 
relative gastrocnemius muscle weight and electrophysiology.  Nerve grafts resulted in 
better functional outcome than anisotropic scaffolds.  However, optimization of LN-1 and 
NGF concentration gradients; and longer duration of experimental study might lead to 
anisotropic scaffolds whose performance is comparable to nerve grafts.   
 Anisotropic scaffolds were synthesized by first making gradients of LN-1 
in agarose gel by diffusion and then immobilizing the protein by photochemical cross-
linking.  Immobilization of LN-1 mimics in vivo conditions where LN-1 is tethered to 
ECM.  Gradients of NGF were designed using slow-release LMTs, which mimics in vivo 
conditions where neurotrophins are released by target organs and taken up by nerve ends.  
The NGF gradient was always a continuous gradient due to the diffusion of NGF from 
LMTs.  However, the LN-1 gradients were of two-kind, a step-gradient and a continuous-
gradient.  The step- and continuous-gradient scaffolds of LN-1 were designed such that 
the average LN-1 concentration in both conditions are similar.  However, the actual 
concentration of LN-1 that the regenerating axons sense dynamically in each condition 
was different due to differing gradient profiles.  The LN-1 concentration range selected 
for making LN-1 step-gradients was based on the maximum concentration of LN-1 that 
could be immobilized.  However, this concentration range may not be the optimal range.  
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A more thorough study will be needed to determine the optimal LN-1 concentration 
range for nerve regeneration. 
 In summary, the in vivo work presents a novel technique to synthesize 
anisotropic scaffolds with gradients of ECM proteins and neurotrophic factors.  These 
anisotropic scaffolds were successful in bridging a challenging 20-mm nerve gap while 
isotropic scaffolds were not successful.  Although anisotropic scaffolds were comparable 
to nerve grafts in histological analysis, nerve grafts resulted in superior functional 
outcome.  Optimization of LN-1 and NGF concentration in the anisotropic scaffold might 
improve its performance to match the nerve grafts. 
 
4.2. Perspectives 
4.2.1. Future studies related to development of in vitro model 
 In this study, LN-1 gradients with three different slopes were tested for promoting 
neurite extension from chick DRG.  The anisotropic scaffold with LN-1 gradient of 0.017 
µg/ml/mm showed the fastest neurite extension.  However, a more thorough study with 
different slopes of LN-1, with different concentration ranges needs to be performed to 
determine the optimal concentration range and slope of LN-1 gradient.  Anisotropic 
scaffolds with different slopes and concentration ranges of LN-1 gradients can be 
synthesized by changing the concentration of LN-1 solution used and the time-duration of 
diffusion process. 
 Although anisotropic scaffolds promote faster neurite extension than isotropic 
scaffolds, the exact mechanism is unknown.  This could be due to regulation of receptors 
for LN-1 by chick DRG.  The study conducted by Condic et al. demonstrated that neurite 
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extension from chick DRG in LN-1 culture is mediated by mostly through α6β1 integrin 
receptors for LN-1.  Chick DRG down-regulate receptors for LN-1 when cultured in high 
concentrations of LN-1 and up-regulate the receptors when cultured in low 
concentrations of LN-1 [2].  However, it is unknown if this mechanism is true for 
gradients as well.  It is possible that in the 0.017 µg/ml/mm LN-1 gradient scaffolds, 
DRGs express more receptors for LN-1 (at the growth cones) than in the 0.051 µg/ml/mm 
and the 0.121 µg/ml/mm gradient scaffolds.  Substrate-cytoskeletal coupling in the 
growth cone could transmit mechanical forces to pull the growth cone or its contents 
toward the anchored adhesive site. Therefore, in the anisotropic LN-1 scaffolds with 
lower slopes, higher density of receptors might lead to faster neurite growth rates by 
haptotactic mechanism.  To establish the exact mechanism, expression of levels of 
receptors for LN-1 need to be determined. 
 
4.2.2. Future studies related to development of in vivo model 
 In this study, gradients (step- or continuous-) of LN-1 and NGF were successful 
in promoting regeneration across a challenging 20-mm nerve gap in rats.  However, the 
concentration of LN-1 and NGF used in our study has not been optimized.  The highest 
possible concentration of LN-1 and NGF was used in this model, which may not be the 
optimal concentration.  A more thorough study involving anisotropic scaffolds with 
different concentrations of LN-1 and NGF would be needed to determine the optimal 
concentration and the optimal slope of gradients of LN-1 and NGF. 
 In the anisotropic scaffolds, majority of the regenerating axons in the anisotropic 
scaffolds were small-diameter (0-2 µm) in nature.  This could be due to the NGF in our 
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scaffolds for nerve regeneration.  NGF mainly promotes the survival and regeneration of 
sensory nerves, which are small-diameter in nature.  BDNF on the other hand promotes 
survival and growth of both sensory and motor neurons.  Using BDNF in our scaffolds 
might lead to regeneration of large-diameter motor neurons and also better motor 
functional outcome.   
 Our anisotropic scaffolds mimic in vivo conditions in presenting gradients 
haptotactic molecule, LN-1, and chemotactic molecule, NGF.  However, studies have 
shown that presence of oriented substrates, such as nanofilaments, to physically guide the 
regenerating axons can further improve nerve regeneration [3].  In future studies, 
incorporation of physical substrates in these anisotropic scaffolds might further improve 
its performance.   
 In this study we have used non-degradable polysulfone tubes to present the 
anisotropic scaffolds.  In clinical studies, after nerve regeneration, a second surgery 
would be needed to remove the non-degradable polysulfone tube, which is undesirable.  
In future studies, this extra procedure could be avoided by using bioresorbable material 
for making the nerve guidance channels, such as polyglycolide (PGA), polylactide 
(PLLA), PGA/PLLA blends and polycaprolactone [4].  
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